Liquid medication control injection device
The drug control injection device addresses the inconvenience and imprecision of existing devices by integrating a blood glucose measuring unit with insulin and glucagon injectors to automatically adjust drug administration based on glucose levels, improving user convenience and stability.
Patent Information
- Application Number
- JP2024137468
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-03-04
- Filing Date
- 2024-08-16
- Publication Date
- 2024-11-06
Smart Images

Figure 2024157012000001_ABST
Abstract
Description
[Technical field]
[0001] SUMMARY OF THE DISCLOSURE Embodiments of the present invention relate to a fluid medicine controlled infusion device. [Background technology]
[0002] When internal functions are not functioning normally, it may be necessary to inject medicinal fluids from outside. For example, when blood sugar levels cannot be regulated, such as in the case of diabetes, it may be necessary to inject medicinal fluids from outside.
[0003] However, such a drug injection device for injecting a drug solution into an injection subject must often be used multiple times or for a long period of time, causing the injection subject to experience inconvenience and pain when using the device.
[0004] Furthermore, in some cases, an infusion subject may require infusion of various medicinal fluids, for example, complementary medicinal fluids that need to be infused in response to a drop or increase in blood glucose levels.
[0005] Meanwhile, in order to increase the effectiveness of drug injections for such patients, the drug injection device needs to be able to precisely control the injection of drug into the patient's body. However, there are limitations to precisely injecting small amounts of drug through a small drug injection device, for example, to inject drug solution sequentially and precisely more than once. Summary of the Invention [Problem to be solved by the invention]
[0006] SUMMARY OF THE DISCLOSURE Embodiments of the present invention provide a drug control infusion device that provides improved convenience and stability. [Means for solving the problem]
[0007] One embodiment of the present invention discloses a drug solution control injection device including a blood glucose measuring unit configured to measure the blood glucose of a subject at least sequentially over a plurality of times, a first drug solution injection unit configured to inject into the subject a first drug solution containing a component that controls a decrease in the blood glucose of the subject, and a second drug solution injection unit configured to inject into the subject a second drug solution containing a component that controls an increase in the blood glucose of the subject and that is different from the first drug solution.
[0008] In the present embodiment, the first liquid medicine injector and the second liquid medicine injector may be configured to selectively inject a first liquid medicine or a second liquid medicine into an injection target.
[0009] In this embodiment, the blood glucose measurement device may further include a control unit configured to control driving of the first liquid medicine injector and the second liquid medicine injector in response to blood glucose information measured by the blood glucose measurement unit.
[0010] In the present embodiment, the first liquid medicinal fluid injector or the second liquid medicinal fluid injector may include a housing, and the blood glucose measuring unit may include a unit disposed within the housing of the first liquid medicinal fluid injector or the second liquid medicinal fluid injector.
[0011] In the present embodiment, the blood glucose measuring unit, the first liquid medicine injecting unit, and the second liquid medicine injecting unit may include a housing formed to contain at least one of the blood glucose measuring unit, the first liquid medicine injecting unit, and the second liquid medicine injecting unit.
[0012] In this embodiment, the drug solution control injection device may be configured to communicate with a terminal provided separately from the drug solution control injection device and transmit one or more pieces of information.
[0013] In this embodiment, the drug solution control injection device may include a device that is attached to the outside of the user's body and has a wearable function.
[0014] Other aspects, features and advantages in addition to those described above will become apparent from the following drawings, claims and detailed description of the invention. Effect of the Invention
[0015] The drug solution control injection device according to this embodiment can improve convenience and stability. [Brief description of the drawings]
[0016] [Figure 1] 1A-1C are illustrative diagrams illustrating the use of a drug solution control infusion device according to one embodiment of the present invention. [Diagram 2] FIG. 2 is a schematic diagram for explaining the drug solution control injection device of FIG. 1. [Diagram 3] 11 is a schematic diagram illustrating a drug solution control injection device according to another embodiment of the present invention. FIG. [Figure 4] 13 is a schematic diagram illustrating a drug solution control injection device according to yet another embodiment of the present invention. FIG. [Diagram 5] 13 is a schematic diagram illustrating a drug solution control injection device according to yet another embodiment of the present invention. FIG. [Figure 6] FIG. 7 is a diagram showing a modification of the first liquid chemical injector of FIG. 5. [Figure 7] 13 is a schematic diagram illustrating a drug solution control injection device according to yet another embodiment of the present invention. FIG. [Figure 8] 8 is a perspective view showing an example of a first chemical liquid injecting section in FIG. 7. [Figure 9] 9 is a schematic plan view of the first chemical liquid injector of FIG. 8. [Figure 10] 13 is a schematic diagram illustrating a drug solution control injection device according to yet another embodiment of the present invention. FIG. [Figure 11] 11 is a perspective view showing an example of a first chemical liquid injecting section of FIG. 10. FIG. [Figure 12] 12 is a schematic front view of the first chemical liquid injector of FIG. 11. [Figure 13] 12 is a schematic plan view of the first chemical liquid injecting section of FIG. 11. [Figure 14] 13 is a schematic diagram illustrating a drug solution control injection device according to yet another embodiment of the present invention. FIG. [Figure 15]13 is a schematic diagram illustrating a drug solution control injection device according to yet another embodiment of the present invention. FIG. [Figure 16] 13 is a schematic diagram illustrating a drug solution control injection device according to yet another embodiment of the present invention. FIG. [Figure 17] 13 is a diagram showing one alternative embodiment of a drive unit included in a drug solution control injection device according to yet another embodiment of the present invention. FIG. [Figure 18] 13 is a diagram showing one alternative embodiment of a drive unit included in a drug solution control injection device according to yet another embodiment of the present invention. FIG. [Figure 19] 13 is a perspective view showing one alternative embodiment of a drive unit included in a drug solution control injection device according to yet another embodiment of the present invention. FIG. [Figure 20] FIG. 20 is a cross-sectional view taken along line XX-XX in FIG. 19. [Figure 21] 13 is a perspective view showing another alternative embodiment of a drug solution control infusion device according to yet another embodiment of the present invention. FIG. MODE FOR CARRYING OUT THEINVENTION
[0017] Since the present invention can be modified in various ways and can have various embodiments, a specific embodiment will be illustrated in the drawings and described in detail. The effects and features of the present invention, as well as methods for achieving them, will become apparent from the following detailed description of the embodiments together with the drawings. However, the present invention is not limited to the embodiments disclosed below, and may be embodied in various forms.
[0018] Hereinafter, an embodiment of the present invention will be described in detail with reference to the accompanying drawings. When describing with reference to the drawings, the same or corresponding components are given the same reference numerals, and duplicate descriptions thereof will be omitted.
[0019] In the following embodiments, the terms "first", "second" and the like are not used in a limiting sense but are used for the purpose of distinguishing one component from another component.
[0020] In the following embodiments, singular expressions include plural expressions unless the context clearly indicates otherwise.
[0021] In the following embodiments, terms such as "include" or "have" mean the presence of features or components described in the specification, and do not preclude the possibility that one or more other features or components may be added.
[0022] In the drawings, the size of components may be exaggerated or reduced for convenience of explanation. For example, the size and thickness of each component shown in the drawings are arbitrarily shown for convenience of explanation, and the present invention is not necessarily limited to those shown.
[0023] In the following embodiments, the x-axis, y-axis, and z-axis are not limited to the three axes on a Cartesian coordinate system, but may be interpreted in a broad sense including them. For example, the x-axis, y-axis, and z-axis may be mutually orthogonal, but may also point in different directions that are not mutually orthogonal.
[0024] When an embodiment can be embodied in other ways, the order of certain steps may be performed out of the order described, for example, two steps described in succession may be performed substantially simultaneously or may be performed in the reverse order from that described.
[0025] FIG. 1 is a diagram illustrating an example of use of a drug solution control infusion device according to one embodiment of the present invention, and FIG. 2 is a schematic diagram for explaining the drug solution control infusion device of FIG.
[0026] Referring to FIG. 1, a medical fluid infusion device 500 is shown positioned externally to a user's body part HB.
[0027] As an example, as shown in FIG. 1, an injection needle for injecting one or more liquid medicines, a sensor for measuring blood glucose, etc. can be inserted through the body part HB.
[0028] If the user has diabetes or has difficulty in controlling blood glucose by his / her own physical ability for other reasons, an abnormal increase or decrease in blood glucose can be controlled by injecting a medicinal liquid from the outside.
[0029] Through the medical fluid injection device 500 of this embodiment, a user can inject different medical fluids to suppress an abnormal increase or decrease in blood glucose.
[0030] Referring to FIG. 2, a liquid medicine injection device 500 of this embodiment may include a blood glucose measuring section 100, a first liquid medicine injection section 200, and a second liquid medicine injection section 300.
[0031] The blood glucose measuring section 100 can be configured to measure the user's blood glucose at least sequentially multiple times.
[0032] As an optional embodiment, the blood glucose measuring unit 100 can measure the user's blood glucose continuously at periodic or irregular intervals for at least a set period of time, and can include, for example, a continuous glucose monitoring (CGM).
[0033] The first liquid medicine injecting unit 200 may be configured to inject a first liquid medicine containing an ingredient for controlling a decrease in blood glucose of the user, reflecting the blood glucose information measured by the blood glucose measuring unit 100, to the user.
[0034] For example, the first medicinal liquid injected into the user via the first medicinal liquid injecting section 200 may contain insulin.
[0035] As an optional embodiment, the first medical fluid injecting unit 200 may include a reservoir (not shown) for storing the first medical fluid.
[0036] Also, as an optional embodiment, the first medicinal liquid injection section 200 may include a module for injecting the first medicinal liquid into the user, such as a needle module (not shown), and the first medicinal liquid can be easily injected inside the user's skin via such a needle module.
[0037] As an alternative embodiment, the first medical liquid injecting unit 200 may include a driving unit (not shown) for transmitting the first medical liquid from the reservoir to the needle module. For example, such a driving unit may include an actuator. The driving unit may also include a pump. By driving the driving unit, a predetermined amount of the first medical liquid may be injected into the user.
[0038] As an alternative embodiment, the driving unit included in the first liquid medicine injector or the second liquid medicine injector in the embodiments described below may also include an actuator, and as another example, may include a pump.
[0039] The first liquid medicine injecting section 200 can use the blood glucose information from the blood glucose measuring section 100 to inject the first liquid medicine once, multiple times, or continuously as necessary.
[0040] As an optional embodiment, the blood glucose measuring section 100 and the first liquid medicine injecting section 200 may include a communication section NW for connecting them so as to transmit information by wire or wirelessly.
[0041] As an optional embodiment, if the blood glucose level measured by the blood glucose measuring unit 100 exceeds a set range, the first medicinal liquid can be injected by the first medicinal liquid injection unit 200 via the control unit (not shown), for example, the drive unit can be controlled via the control unit (not shown) to control the injection of the medicinal liquid into the needle module.
[0042] Such a control unit (not shown) can be included in the blood glucose measuring unit 100, and can be included in the first liquid medicine injecting unit 200 or the second liquid medicine injecting unit 300.
[0043] In addition, a control unit (not shown) can be disposed as a separate member.
[0044] As an optional embodiment, the control unit can notify a user or the like of the value measured by the blood glucose measuring unit 100, and the user can operate the control unit to control the injection of the first liquid medicine injection unit 200 or the second liquid medicine injection unit 300.
[0045] As an optional embodiment, the controller can sense and control the interaction of the injections of the first medical fluid injector 200 or the second medical fluid injector 300. For example, the controller can reduce or prevent the effects of the interaction between the first medical fluid and the second medical fluid.
[0046] For example, the control unit can limit the injection of the second liquid medicine during the maximum effect time due to the injection of the first liquid medicine after the injection of the first liquid medicine, and as a specific example, can block the injection of the second liquid medicine or reduce the injection of the second liquid medicine. Such a maximum effect time may be a preset time. In addition, as an optional embodiment, the maximum effect time is a variable value, and the control unit can calculate the maximum effect time by grasping the value measured by the blood glucose measuring unit 100 or a change in such value, and at that time, can analyze whether to block the injection of the second liquid medicine or reduce the injection of the second liquid medicine.
[0047] As another example, the control unit may limit the injection of the first liquid medicine during the time when the second liquid medicine is injected and the first liquid medicine is injected for the maximum effect time, and as a specific example, may block the injection of the first liquid medicine or reduce the injection of the first liquid medicine. Such a maximum effect time may be a preset time. In addition, as an optional embodiment, the maximum effect time is a variable value, and the control unit may calculate the maximum effect time by grasping the value measured by the blood glucose measuring unit 100 or a change in such value, and may analyze whether to block the injection of the first liquid medicine or reduce the injection of the first liquid medicine.
[0048] As an alternative embodiment, the control unit can calculate the injection amount of each of the first and second liquid medicines taking into account the antagonism between the first and second liquid medicines.
[0049] For example, the half-life and the time until complete elimination of the first and second liquid drugs can be used, and these values may be preset values. Using such time information, the injection amount of each liquid drug can be calculated.
[0050] The first and second chemical liquid injections of the control unit can be selectively applied to all of the embodiments described below.
[0051] On the other hand, in the embodiment described below, when a needle module for injecting a first drug liquid and a needle module for injecting a second drug liquid are provided, the injection of the first drug liquid and the second drug liquid can be easily controlled individually by controlling each needle module.
[0052] Furthermore, when a common needle module is formed for the first and second chemical liquid injections, control can be performed using valve VL, as a specific example, in the case of Fig. 15. As an optional embodiment, a first chemical liquid injection limiting member (not shown) can be further disposed between valve VL and first chemical liquid injection unit 7200 or in first chemical liquid injection unit 7200, whereby restriction of the first chemical liquid can be easily controlled when unwanted mixing must be restricted, such as in the case of exchange injection of the first and second chemical liquids.
[0053] Furthermore, as an optional embodiment, a second chemical liquid injection restriction member (not shown) can be further disposed between the valve VL and the second chemical liquid injection section 7300 or in the second chemical liquid injection section 7300, thereby making it possible to easily control the restriction of the second chemical liquid when it is necessary to restrict unwanted mixing, such as in the exchange injection of the first and second chemical liquids.
[0054] The second liquid medicine injecting unit 300 may be configured to inject a second liquid medicine containing an ingredient for controlling an increase in the blood glucose of the user, reflecting the blood glucose information measured by the blood glucose measuring unit 100, to the user.
[0055] For example, the second medical fluid injected into the user via second medical fluid injector 300 may contain glucagon.
[0056] As an optional embodiment, the second medical fluid injecting section 300 may include a reservoir (not shown) for storing the second medical fluid.
[0057] Also, as an optional embodiment, the second medicinal liquid injection section 300 may include a module for injecting the second medicinal liquid into the user, such as a needle module (not shown), and the second medicinal liquid can be easily injected inside the user's skin via such a needle module.
[0058] As an optional embodiment, the second medical fluid injecting unit 300 may include a driving unit (not shown) for transmitting the second medical fluid from the reservoir to the needle module. For example, such a driving unit may include a pump, and a predetermined amount of the second medical fluid may be injected into the user by pumping the pump.
[0059] The second liquid medicine injecting section 300 can use the blood glucose information from the blood glucose measuring section 100 to inject the second liquid medicine once, multiple times, or continuously as necessary.
[0060] As an optional embodiment, the blood glucose measuring section 100 and the second liquid medicine injecting section 300 may include a communication section NW for transmitting information by wire or wirelessly.
[0061] As an optional embodiment, when the blood glucose level measured by the blood glucose measuring unit 100 falls below a set range, the second medicinal liquid can be injected by the second medicinal liquid injection unit 300 via the control unit (not shown), for example, by controlling the drive unit to control the injection of the medicinal liquid into the needle module.
[0062] The drug solution control infusion device of the present embodiment can measure the blood glucose of the user at least multiple times via the blood glucose measuring unit, or can perform periodic or irregular continuous blood glucose measurement as an optional embodiment. As a specific example, real-time blood glucose measurement can be performed.
[0063] Using the user's blood glucose information measured by such a blood glucose measuring section, the first and second liquid drug injectors of the liquid drug control injection device can selectively inject the first or second liquid drug.
[0064] As a result, a user, for example a user who has difficulty controlling blood sugar, can easily achieve precise blood sugar control through the drug solution control injection device.
[0065] For example, if the blood glucose level measured by the blood glucose measuring unit exceeds a set range, a first medicinal liquid such as insulin can be injected via the first medicinal liquid injection unit to reduce the blood glucose level and bring it within the normal blood glucose range.
[0066] As another example, if the blood glucose level measured by the blood glucose measuring unit is below a set range, a second medicinal liquid such as glucagon can be injected via the second medicinal liquid injection unit to increase the blood glucose level and bring it within the normal blood glucose range.
[0067] Such control can be implemented in various ways. For example, a user or guardian can recognize the value measured by the blood glucose measuring unit and control a control unit that drives the first liquid medicinal injection unit or the second liquid medicinal injection unit.
[0068] As another example, the control unit can receive blood glucose level information measured by the blood glucose measuring unit in real time according to a preset blood glucose setting range, and if the set range is exceeded, a first medicinal liquid is injected via a first medicinal liquid injection unit, and if the set range is below, a second medicinal liquid is injected via a second medicinal liquid injection unit.
[0069] This improves convenience for the user, eliminates inaccuracies in adjusting the medicinal liquid due to the user's inexperience, and enables precise control of the injection of the first and second medicinal liquids, thereby enabling precise control of the user's blood sugar.
[0070] FIG. 3 is a schematic diagram illustrating a drug solution control injection device according to another embodiment of the present invention.
[0071] Referring to FIG. 3, a liquid medicine injection device 1500 of this embodiment may include a blood glucose measuring section 1100, a first liquid medicine injection section 1200, and a second liquid medicine injection section 1300.
[0072] The blood glucose measuring unit 1100 can be configured to measure the user's blood glucose at least sequentially multiple times.
[0073] As an optional embodiment, the blood glucose measurement unit 1100 can measure the user's blood glucose continuously at periodic or irregular intervals for at least a set period of time, and can include, for example, a continuous glucose monitoring (CGM).
[0074] The blood glucose measuring unit 1100 may be formed so as to be included in the first liquid medicine injecting unit 1200. For example, the blood glucose measuring unit 1100 may be disposed in part or in its entirety inside a housing (not shown) of the first liquid medicine injecting unit 1200.
[0075] The first medicinal liquid injecting unit 1200 may be configured to inject a first medicinal liquid containing an ingredient for controlling a decrease in blood glucose of the user, reflecting the blood glucose information measured by the blood glucose measuring unit 1100, to the user.
[0076] For example, the first medicinal liquid injected into the user via the first medicinal liquid injecting section 1200 may include insulin.
[0077] As an optional embodiment, the first medical fluid injecting section 1200 may include a reservoir (not shown) for storing the first medical fluid.
[0078] Also, as an optional embodiment, the first medicinal liquid injection section 1200 may include a module for injecting the first medicinal liquid into the user, such as a needle module (not shown), and the first medicinal liquid can be easily injected inside the user's skin via such a needle module.
[0079] As an optional embodiment, the first medical solution injecting unit 1200 may include a driving unit (not shown) for transferring the first medical solution from the reservoir to the needle module. For example, such a driving unit may include a pump, and a predetermined amount of the first medical solution may be injected into the user by pumping the pump.
[0080] The first liquid medicine injecting section 1200 can use the blood glucose information from the blood glucose measuring section 1100 to inject the first liquid medicine once, multiple times, or continuously as necessary.
[0081] The first liquid medicine injecting section 1200 may be integrally formed with the blood glucose measuring section 1100. For example, at least a region of the blood glucose measuring section 1100 may be disposed within a region of the first liquid medicine injecting section 1200, for example, within a housing.
[0082] Also, as an optional embodiment, the blood glucose measuring unit 1100 may be formed on one area of the first medical fluid injecting unit 1200, for example, on a main body portion in the form of a substrate.
[0083] As an optional embodiment, if the blood glucose level measured by the blood glucose measuring unit 1100 exceeds a set range, the first medicinal liquid can be injected by the first medicinal liquid injection unit 1200 via a control unit (not shown), for example, the drive unit can be controlled via the control unit (not shown) to control the injection of the medicinal liquid into the needle module.
[0084] Such a control unit (not shown) can be included in the blood glucose measuring unit 1100, or in the first liquid medicine injecting unit 1200 or the second liquid medicine injecting unit 1300.
[0085] In addition, a control unit (not shown) can be disposed as a separate member.
[0086] As an optional embodiment, the control unit can notify a user or the like of the value measured by the blood glucose measuring unit 1100, and the user can operate the control unit to control the injection of the first liquid medicine injection unit 1200 or the second liquid medicine injection unit 1300.
[0087] The second liquid medicine injecting unit 1300 may be configured to inject a second liquid medicine containing an ingredient for controlling an increase in the user's blood sugar, reflecting the blood sugar information measured by the blood sugar measuring unit 1100, to the user.
[0088] For example, the second medical fluid injected into the user via second medical fluid injector 1300 may include glucagon.
[0089] As an optional embodiment, the second medical fluid injecting section 1300 may include a reservoir (not shown) for storing the second medical fluid.
[0090] Also, as an optional embodiment, the second medicinal liquid injection section 1300 may include a module for injecting the second medicinal liquid into the user, such as a needle module (not shown), and the second medicinal liquid can be easily injected inside the user's skin via such a needle module.
[0091] As an optional embodiment, the second medical fluid injecting unit 1300 may include a driving unit (not shown) for transmitting the second medical fluid from the reservoir to the needle module. For example, such a driving unit may include a pump, and a predetermined amount of the second medical fluid may be injected into the user by pumping the pump.
[0092] The second liquid medicine injecting section 1300 can use the blood glucose information from the blood glucose measuring section 1100 to inject the second liquid medicine once, multiple times, or continuously as necessary.
[0093] As an optional embodiment, the blood glucose measuring section 1100 and the second liquid medicine injecting section 1300 may include a communication section NW for transmitting information by wire or wirelessly.
[0094] As an optional embodiment, when the blood glucose level measured by the blood glucose measuring unit 1100 falls below a set range, the second medicinal liquid can be injected by the second medicinal liquid injection unit 1300 via the control unit (not shown), for example, by controlling the drive unit to control the injection of the medicinal liquid into the needle module.
[0095] The drug solution control infusion device of the present embodiment can measure the blood glucose of the user at least multiple times via the blood glucose measuring unit, or can perform periodic or irregular continuous blood glucose measurement as an optional embodiment. As a specific example, real-time blood glucose measurement can be performed.
[0096] Using the user's blood glucose information measured by such a blood glucose measuring section, the first and second liquid drug injectors of the liquid drug control injection device can selectively inject the first or second liquid drug.
[0097] As a result, a user, for example a user who has difficulty controlling blood sugar, can easily achieve precise blood sugar control through the drug solution control injection device.
[0098] Also, the blood glucose measuring unit may be included in the first liquid medicinal fluid injecting unit, or may be formed to include at least one region thereof. For example, at least one region of the blood glucose measuring unit may be disposed within a housing of the first liquid medicinal fluid injecting unit, and as one example, at least one region of the blood glucose measuring unit may be disposed in a substrate-shaped main body of the first liquid medicinal fluid injecting unit.
[0099] Furthermore, the blood glucose measuring section may be integrated with the first liquid medicinal fluid injecting section, which can improve the convenience of handling and management of the blood glucose measuring section and the first liquid medicinal fluid injecting section.
[0100] Although not shown, the blood glucose measuring section may be included in the second liquid medicine injecting section, or may be formed so as to include at least one region thereof.
[0101] The medicinal liquid control injection device of this embodiment enhances convenience for the user and enables precise control of the injection of the first and second medicinal liquids, thereby enabling precise control of the user's blood sugar.
[0102] FIG. 4 is a schematic diagram illustrating a drug solution control injection device according to still another embodiment of the present invention.
[0103] Referring to FIG. 4, a liquid medicine injection device 2500 of this embodiment can include a blood glucose measuring section 2100, a first liquid medicine injection section 2200, a second liquid medicine injection section 2300, and a housing 2510.
[0104] The housing 2510 can have a unitary form, for example, a box shape.
[0105] As an alternative embodiment, the housing 2510 can have a configuration that includes a separate cover.
[0106] A part or the entire area of the blood glucose measuring section 2100, the first liquid medicine injecting section 2200, and the second liquid medicine injecting section 2300 can be covered by the housing 2510.
[0107] For example, the cover (not shown) of the housing 2510 may have a configuration in which the blood glucose measuring section 2100, the first liquid medicine injecting section 2200, and the second liquid medicine injecting section 2300 are partially or entirely covered.
[0108] The blood glucose measuring section 2100 can be configured to measure the user's blood glucose at least sequentially multiple times.
[0109] As an optional embodiment, the blood glucose measurement unit 2100 can measure the user's blood glucose continuously at periodic or irregular intervals for at least a set period of time, and can include, for example, a continuous glucose monitoring (CGM).
[0110] The first liquid medicine injecting unit 2200 may be configured to inject a first liquid medicine containing an ingredient for controlling a decrease in blood glucose of the user, reflecting the blood glucose information measured by the blood glucose measuring unit 2100, to the user.
[0111] For example, the first medicinal liquid injected into the user via the first medicinal liquid injecting section 2200 may include insulin.
[0112] As an optional embodiment, the first medical fluid injecting section 2200 may include a reservoir (not shown) for storing the first medical fluid.
[0113] Also, as an optional embodiment, the first medicinal liquid injection section 2200 may include a module for injecting the first medicinal liquid into the user, such as a needle module (not shown), and the first medicinal liquid can be easily injected inside the user's skin via such a needle module.
[0114] As an optional embodiment, the first medical solution injecting unit 2200 may include a driving unit (not shown) for transmitting the first medical solution from the reservoir to the needle module. For example, such a driving unit may include a pump, and a predetermined amount of the first medical solution may be injected into the user by pumping the pump.
[0115] The first liquid medicine injecting section 2200 can use the blood glucose information from the blood glucose measuring section 2100 to inject the first liquid medicine once, multiple times, or continuously as necessary.
[0116] As an optional embodiment, the blood glucose measuring unit 2100 and the first liquid medicine injecting unit 2200 may include a communication unit NW for connecting them so as to transmit information by wire or wirelessly.
[0117] As an optional embodiment, if the blood glucose level measured by the blood glucose measuring unit 2100 exceeds a set range, the first medicinal liquid can be injected by the first medicinal liquid injection unit 2200 via a control unit (not shown), for example, the drive unit can be controlled via the control unit (not shown) to control the injection of the medicinal liquid into the needle module.
[0118] Such a control unit (not shown) can be included in the blood glucose measuring unit 2100, and can be included in the first liquid medicine injecting unit 2200 or the second liquid medicine injecting unit 2300.
[0119] In addition, a control unit (not shown) can be disposed as a separate member.
[0120] As an optional embodiment, the control unit can notify a user or the like of the value measured by the blood glucose measuring unit 2100, and the user can operate the control unit to control the injection of the first liquid medicine injection unit 2200 or the second liquid medicine injection unit 2300.
[0121] The second liquid medicine injecting unit 2300 may be configured to inject a second liquid medicine containing an ingredient for controlling an increase in the blood glucose of the user, reflecting the blood glucose information measured by the blood glucose measuring unit 2100, to the user.
[0122] For example, the second medical fluid infused to the user via second medical fluid infusion section 2300 may include glucagon.
[0123] As an optional embodiment, the second medical fluid injecting section 2300 may include a reservoir (not shown) for storing the second medical fluid.
[0124] Also, as an optional embodiment, the second medicinal liquid injection section 2300 may include a module for injecting the second medicinal liquid into the user, such as a needle module (not shown), and the second medicinal liquid can be easily injected inside the user's skin via such a needle module.
[0125] As an optional embodiment, the second medical fluid injecting unit 2300 may include a driving unit (not shown) for transmitting the second medical fluid from the reservoir to the needle module. For example, such a driving unit may include a pump, and a predetermined amount of the second medical fluid may be injected into the user by pumping the pump.
[0126] The second liquid medicine injecting section 2300 can use the blood glucose information from the blood glucose measuring section 2100 to inject the second liquid medicine once, multiple times, or continuously as necessary.
[0127] As an optional embodiment, the blood glucose measuring section 2100 and the second liquid medicine injecting section 2300 may include a communication section NW for transmitting information by wire or wirelessly.
[0128] As an optional embodiment, when the blood glucose level measured by the blood glucose measuring unit 2100 falls below a set range, the second medicinal liquid can be injected by the second medicinal liquid injection unit 2300 via the control unit (not shown), for example, by controlling the drive unit to control the injection of the medicinal liquid into the needle module.
[0129] The drug solution control infusion device of the present embodiment can measure the blood glucose of the user at least multiple times via the blood glucose measuring unit, or can perform periodic or irregular continuous blood glucose measurement as an optional embodiment. As a specific example, real-time blood glucose measurement can be performed.
[0130] Using the user's blood glucose information measured by such a blood glucose measuring section, the first and second liquid drug injectors of the liquid drug control injection device can selectively inject the first or second liquid drug.
[0131] As a result, a user, for example a user who has difficulty controlling blood sugar, can easily achieve precise blood sugar control through the drug solution control injection device.
[0132] The housing may be formed so that all or at least a portion of the blood glucose measuring unit, the first liquid medicine injecting unit, and the second liquid medicine injecting unit are included in the housing. For example, a cover included in the housing may cover the blood glucose measuring unit, the first liquid medicine injecting unit, or the second liquid medicine injecting unit.
[0133] In addition, the blood glucose measuring unit, the first medicinal liquid injection unit and the second medicinal liquid injection unit can be integrated into a single housing, thereby improving the convenience of handling and management of the blood glucose measuring unit, the first medicinal liquid injection unit and the second medicinal liquid injection unit.
[0134] The drug solution control injection device of this embodiment enhances convenience for the user and enables precise control of the injection of the first and second drug solutions, thereby enabling precise control of the user's blood sugar.
[0135] FIG. 5 is a schematic diagram illustrating a drug solution control injection device according to still another embodiment of the present invention.
[0136] 5, a liquid medicine injection device 3500 of this embodiment may include a blood glucose measuring section 3100, a first liquid medicine injection section 3200, and a second liquid medicine injection section 3300. In the embodiment shown in FIG.
[0137] Although not shown, as an optional embodiment, the drug solution injection device 3500 of this embodiment may further include a housing (not shown) as described in the previous embodiment.
[0138] The blood glucose measuring section 3100 can be configured to measure the user's blood glucose at least sequentially multiple times.
[0139] As an optional embodiment, the blood glucose measurement unit 3100 can measure the user's blood glucose continuously at periodic or irregular intervals for at least a set period of time, and can include, for example, a continuous glucose monitoring (CGM).
[0140] The first medicinal liquid injecting unit 3200 may be configured to inject a first medicinal liquid, which includes an ingredient for controlling a decrease in blood glucose of the user, into the user, in response to blood glucose information measured by the blood glucose measuring unit 3100 .
[0141] For example, the first medicinal liquid injected into the user via the first medicinal liquid injecting section 3200 may include insulin.
[0142] As an optional embodiment, the first medical fluid injecting section 3200 may include a reservoir 3210 for storing the first medical fluid.
[0143] The reservoir 3210 includes one or more outer portions 3211 and is capable of housing a first medical fluid in an interior space formed inside the outer portions 3211 .
[0144] The storage unit 3210 may include a storage space in the form of a tank for storing the liquid medicine. The storage unit 3210 may include a waterproof material capable of storing the liquid medicine, such as a plastic material, or may be formed of various other materials. For example, the storage unit 3210 may include a glass, metal, or silicon material.
[0145] Also, although not shown, the storage portion 3210 may include one or more moving members (not shown) in the space inside the outer portion 3211 where the medicinal liquid is contained, and such moving members enable the first medicinal liquid to move effectively, specifically, to easily transmit the medicinal liquid contained in the storage portion 3210 to the needle module 3230 described later.
[0146] Also, as an optional embodiment, the first medical fluid injector 3200 may include a module, for example a needle module 3230, for injecting the first medical fluid into the user.
[0147] The needle module 3230 may include at least one needle portion ND. The needle portion ND is hollow, and the first medicinal liquid in the reservoir 3210 may be injected into the injection target through the internal space.
[0148] A connection part TN may be disposed between the needle module 3230 and the storage part 3210. The connection part TN may include a transfer area for transferring at least the first medicinal solution of the storage part 3210 to the needle module 3230, and may include, for example, a hollow tube shape.
[0149] The connector TN can be formed in various forms, including, for example, a flexible tube form.
[0150] Through such a needle module 3230, the first medicinal liquid can be easily injected into the inside of the user's skin.
[0151] As an optional embodiment, the first medical fluid injector 3200 may include a driver 3220 for transferring the first medical fluid from the reservoir to the needle module.
[0152] The driving unit 3220 enables the first medicinal liquid stored in the storage unit 3210 to be transferred to the needle module 3230, so that the first medicinal liquid can be easily injected from the needle module 3230 into the target for medicinal liquid injection, for example, the inside of a person's skin.
[0153] As an alternative embodiment, the driving unit 3220 may include a pump, and the first medicinal liquid stored in the reservoir 3210 may be transferred in a predetermined amount toward the needle module 3230 through pumping of the pump.
[0154] Although not shown, the driving unit 3220 may be connected to a power supply unit (not shown), and such a power supply may have various types of forms such as an external power supply, a disposable battery, or a rechargeable battery.
[0155] As an alternative embodiment, the driving unit 3220 may be electrically connected to a controller (not shown) and the driving unit 3220 may control the injection of the first medicinal liquid through the control of the controller.
[0156] The driving unit 3220 may be any type of pump having a liquid suction force and a liquid discharge force by electricity. For example, any type of pump such as a mechanical displacement type micropump or an electromagnetic movement type micropump may be used. The mechanical displacement type micropump is a pump that uses the movement of a solid or fluid such as a gear or a diaphragm to generate a pressure difference to induce a fluid flow, and includes a diaphragm displacement pump, a fluid displacement pump, a rotary pump, etc. The electromagnetic movement type micropump is a pump that uses an electric or magnetic form of energy directly to move a fluid, and includes an electrohydrodynamic pump (EHD), an electroosmotic pump, a magnetohydrodynamic pump, an electrowetting pump, etc.
[0157] The driving part 3220 of the present embodiment is connected to the storage part 3210 so that the first medicinal liquid contained in the storage part 3210 can be easily transferred to the needle module 3230 through the connection part TN.
[0158] The first liquid medicine injecting section 3200 can use the blood glucose information from the blood glucose measuring section 3100 to inject the first liquid medicine once, multiple times, or continuously as necessary.
[0159] As an optional embodiment, the blood glucose measuring unit 3100 and the first liquid medicine injecting unit 3200 may include a communication unit NW for connecting them so as to transmit information by wire or wirelessly.
[0160] As an optional embodiment, if the blood glucose level measured by the blood glucose measuring unit 3100 exceeds a set range, the first medicinal liquid can be injected by the first medicinal liquid injection unit 3200 via the control unit (not shown), for example, the drive unit 3220 can be controlled via the control unit (not shown) to control the injection of the medicinal liquid by the needle module 3230.
[0161] Such a control unit (not shown) can be included in the blood glucose measuring unit 3100, or in the first liquid medicine injecting unit 3200 or the second liquid medicine injecting unit 3300.
[0162] In addition, a control unit (not shown) can be disposed as a separate member.
[0163] As an optional embodiment, the control unit can notify a user or the like of the value measured by the blood glucose measuring unit 3100, and the user can operate the control unit to control the injection of the first liquid medicine injection unit 3200 or the second liquid medicine injection unit 3300.
[0164] FIG. 6 is a diagram showing a modification of the first liquid medicine injector of FIG.
[0165] Referring to FIG. 6, a first medical solution injecting unit 3200' may include a reservoir 3210', a driver 3220', and a needle module 3230'.
[0166] The first connector TN1 may be disposed between the storage unit 3210' and the actuator 3220', and may include a transmission region such that at least the first drug solution in the storage unit 3210' is transmitted in the direction of the actuator 3220', and may have, for example, a hollow tube shape. The first connector TN1 may be formed in various shapes, and may have, for example, a flexible tube shape.
[0167] The second connector TN2 may be disposed between the actuator 3220' and the needle module 3230', and may include a transmission region for transmitting at least the first medicinal solution from the actuator 3220' to the needle module 3230', for example, a hollow tube shape. The second connector TN2 may be formed in various shapes, for example, a flexible tube shape.
[0168] The second liquid medicine injecting unit 3300 may be configured to inject a second liquid medicine containing an ingredient for controlling an increase in the blood glucose of the user, reflecting the blood glucose information measured by the blood glucose measuring unit 3100, to the user.
[0169] For example, the second medical fluid infused to the user via second medical fluid infusion section 3300 may include glucagon.
[0170] As an optional embodiment, the second medical fluid injecting section 3300 may include a reservoir (not shown) for storing the second medical fluid.
[0171] Also, as an optional embodiment, the second medicinal liquid injection section 3300 may include a module for injecting the second medicinal liquid into the user, such as a needle module (not shown), and the second medicinal liquid can be easily injected inside the user's skin via such a needle module.
[0172] As an optional embodiment, the second medical fluid injecting unit 3300 may include a driving unit (not shown) for transmitting the second medical fluid from the reservoir to the needle module. For example, such a driving unit may include a pump, and a predetermined amount of the second medical fluid may be injected into the user by pumping the pump.
[0173] The second liquid medicine injecting section 3300 can use the blood glucose information from the blood glucose measuring section 3100 to inject the second liquid medicine once, multiple times, or continuously as necessary.
[0174] As an optional embodiment, the blood glucose measuring section 3100 and the second liquid medicine injecting section 3300 may include a communication section NW for transmitting information by wire or wirelessly.
[0175] As an optional embodiment, if the blood glucose level measured by the blood glucose measuring unit 3100 falls below a set range, the second medicinal liquid can be injected by the second medicinal liquid injection unit 3300 via the control unit (not shown), for example, by controlling the drive unit to control the injection of the medicinal liquid into the needle module.
[0176] Although not shown, the second medical solution injecting unit 3300 may include all or part of the same components as the driving unit, the storage unit, and the needle module included in the first medical solution injecting unit 3200. In addition, the second medical solution injecting unit 3300 may include the same components or part as the modified example of FIG.
[0177] The drug solution control infusion device of the present embodiment can measure the blood glucose of the user at least multiple times via the blood glucose measuring unit, or can perform periodic or irregular continuous blood glucose measurement as an optional embodiment. As a specific example, real-time blood glucose measurement can be performed.
[0178] Using the user's blood glucose information measured by such a blood glucose measuring section, the first and second liquid drug injectors of the liquid drug control injection device can selectively inject the first or second liquid drug.
[0179] As a result, a user, for example a user who has difficulty controlling blood sugar, can easily achieve precise blood sugar control through the drug solution control injection device.
[0180] In addition, the first or second liquid medicine injector may include a storage unit for storing the liquid medicine, a needle module formed to inject the liquid medicine into the injection target, and a drive unit for driving the movement of the liquid medicine. With this configuration, smooth injection of the first or second liquid medicine can be easily implemented.
[0181] As a result, the medicinal liquid control injection device of this embodiment enhances convenience for the user and enables precise control of the injection of the first and second medicinal liquids, thereby enabling precise control of the user's blood sugar.
[0182] FIG. 7 is a schematic diagram for illustrating a drug liquid control injection device relating to yet another embodiment of the present invention, FIG. 8 is an oblique view showing an example of the first drug liquid injection section of FIG. 7, and FIG. 9 is a schematic plan view of the first drug liquid injection section of FIG. 8.
[0183] 7 to 9, a liquid medicine injection device 4500 of this embodiment may include a blood glucose measuring section 4100, a first liquid medicine injection section 4200, and a second liquid medicine injection section 4300.
[0184] Although not shown, as an optional embodiment, the drug solution injection device 4500 of this embodiment may further include a housing (not shown) as described in the previous embodiment.
[0185] The blood glucose measuring unit 4100 can be configured to measure the user's blood glucose at least sequentially multiple times.
[0186] As an optional embodiment, the blood glucose measurement unit 4100 can measure the user's blood glucose continuously at periodic or irregular intervals for at least a set period of time, and can include, for example, a continuous glucose monitoring device (CGM).
[0187] The first medical solution injecting section 4200 may include a cover 4201 , which may be formed to cover the storage section 4210 , the driving section 4220 , and the needle module 4230 .
[0188] For ease of explanation, FIG. 9 shows a state in which the cover 4201 of FIG. 8 has been removed.
[0189] The first medical solution injecting portion 4200 may include a base 4202 , and the base 4202 may be formed to face the cover 4201 .
[0190] As an optional embodiment, the cover 4201 and the base 4202 may be coupled to each other to form a housing for the first medical fluid injecting portion 4200 .
[0191] In an optional embodiment, the cover 4201 can include an opening, with a button 4235 positioned to correspond to such opening, said button 4235 can correspond to a needle module 4230 .
[0192] For example, a button 4235 can be disposed on the needle module 4230 and the button 4235 can be configured to allow a user to press or rotate the button 4235. Movement relative to the needle module 4230 is possible through the button 4235.
[0193] The first medicinal liquid injecting unit 4200 may be configured to inject a first medicinal liquid containing an ingredient for controlling a decrease in blood glucose of the user, reflecting the blood glucose information measured by the blood glucose measuring unit 4100, to the user.
[0194] For example, the first medicinal liquid injected into the user via the first medicinal liquid injecting section 4200 may include insulin.
[0195] As an optional embodiment, the first medical fluid injecting section 4200 may include a reservoir 4210 for storing the first medical fluid.
[0196] The reservoir 4210 includes one or more outer portions 4211 and is capable of housing a first medical fluid in an interior space formed inside the outer portions 4211 .
[0197] The storage unit 4210 may include a storage space in the form of a tank for storing the liquid medicine. The storage unit 4210 may include a waterproof material capable of storing the liquid medicine, for example, a plastic-based material, or may be formed of various other materials. For example, the storage unit 4210 may include a glass, metal, or silicon material.
[0198] Also, although not shown, the storage portion 4210 may include one or more moving members (not shown) in the space inside the outer portion 4211 where the medicinal liquid is contained, and such moving members enable the first medicinal liquid to move effectively, specifically, to easily transmit the medicinal liquid contained in the storage portion 4210 to the needle module 4230 described later.
[0199] Although not shown, the reservoir 4210 also includes a filling passage (not shown) through which the medicinal liquid can be replenished.
[0200] Also, as an optional embodiment, the first medical fluid injector 4200 may include a module, for example a needle module 4230, for injecting the first medical fluid into the user.
[0201] The needle module 4230 may include at least one needle portion ND. The needle portion ND is hollow, and the first medicinal liquid in the reservoir 4210 may be injected into the injection target through the internal space.
[0202] A connection part TN may be disposed between the needle module 4230 and the storage part 4210. The connection part TN may include a transfer region such that at least the first medicinal solution in the storage part 4210 is transferred to the needle module 4230, and may include, for example, a hollow tube shape.
[0203] The connector TN can be formed in various forms, including, for example, a flexible tube form.
[0204] Through such a needle module 4230, the first medicinal liquid can be easily injected into the inside of the user's skin.
[0205] As an optional embodiment, the first medical fluid injector 4200 can include a driver 4220 for transferring the first medical fluid from the reservoir to the needle module.
[0206] The driving unit 4220 enables the first medicinal liquid stored in the storage unit 4210 to be transferred to the needle module 4230, so that the first medicinal liquid can be easily injected from the needle module 4230 into the target for medicinal liquid injection, for example, the inside of a person's skin.
[0207] As an alternative embodiment, the driving unit 4220 may include a pump, and the first medicinal liquid stored in the reservoir 4210 may be transferred in a predetermined amount toward the needle module 4230 through pumping of the pump.
[0208] The driving unit 4220 may be connected to a power supply unit 4250, which may include a battery and may have various types of forms such as a disposable battery or a rechargeable battery.
[0209] As an alternative embodiment, the driving unit 4220 may be electrically connected to a controller (not shown) and may control the injection of the first medicinal liquid through the control of the controller.
[0210] The driving unit 4220 may be any type of pump having a liquid suction force and a liquid discharge force by electricity. For example, any type of pump such as a mechanical displacement type micropump or an electromagnetic movement type micropump may be used. The mechanical displacement type micropump is a pump that uses the movement of a solid or fluid such as a gear or a diaphragm to generate a pressure difference to induce a fluid flow, and includes a diaphragm displacement pump, a fluid displacement pump, a rotary pump, etc. The electromagnetic movement type micropump is a pump that uses an electric or magnetic form of energy directly to move a fluid, and includes an electrohydrodynamic pump (EHD), an electroosmotic pump, a magnetohydrodynamic pump, an electrowetting pump, etc.
[0211] The driving part 4220 of this embodiment is connected to the storage part 4210 so that the first medicinal liquid contained in the storage part 4210 can be easily transferred to the needle module 4230 through the connection part TN.
[0212] The first liquid medicine injecting section 4200 can use the blood glucose information from the blood glucose measuring section 4100 to inject the first liquid medicine once, multiple times, or continuously as necessary.
[0213] As an optional embodiment, the blood glucose measuring unit 4100 and the first liquid medicine injecting unit 4200 may include a communication unit NW for connecting them so as to transmit information by wire or wirelessly.
[0214] As an optional embodiment, if the blood glucose level measured by the blood glucose measuring unit 4100 exceeds a set range, the first medicinal liquid can be injected by the first medicinal liquid injection unit 4200 via the control unit (not shown), for example, the drive unit 4220 can be controlled via the control unit (not shown) to control the injection of the medicinal liquid by the needle module 4230.
[0215] Such a control unit (not shown) can be included in the blood glucose measuring unit 4100, and can be included in the first liquid medicine injecting unit 4200 or the second liquid medicine injecting unit 4300.
[0216] In addition, a control unit (not shown) can be disposed as a separate member.
[0217] As an optional embodiment, the control unit can notify a user or the like of the value measured by the blood glucose measuring unit 4100, and the user can operate the control unit to control the injection of the first liquid medicine injection unit 4200 or the second liquid medicine injection unit 4300.
[0218] The second liquid medicine injecting unit 4300 may be configured to inject a second liquid medicine containing an ingredient for controlling an increase in the blood glucose of the user, reflecting the blood glucose information measured by the blood glucose measuring unit 4100, to the user.
[0219] For example, the second medical fluid infused to the user via second medical fluid infusion section 4300 may include glucagon.
[0220] As an optional embodiment, the second medical fluid injecting section 4300 may include a reservoir (not shown) for storing the second medical fluid.
[0221] Also, as an optional embodiment, the second medicinal liquid injection section 4300 may include a module for injecting the second medicinal liquid into the user, such as a needle module (not shown), and the second medicinal liquid can be easily injected inside the user's skin via such a needle module.
[0222] As an optional embodiment, the second medical fluid injecting unit 4300 may include a driving unit (not shown) that transfers the second medical fluid from the reservoir to the needle module. For example, such a driving unit may include a pump, and a predetermined amount of the second medical fluid may be injected into the user by pumping the pump.
[0223] The second liquid medicine injecting section 4300 can use the blood glucose information from the blood glucose measuring section 4100 to inject the second liquid medicine once, multiple times, or continuously as necessary.
[0224] As an optional embodiment, the blood glucose measuring section 4100 and the second liquid medicine injecting section 4300 may include a communication section NW for transmitting information by wire or wirelessly.
[0225] As an optional embodiment, if the blood glucose level measured by the blood glucose measuring unit 4100 falls below a set range, the second medicinal liquid can be injected by the second medicinal liquid injection unit 4300 via the control unit (not shown), for example, by controlling the drive unit to control the injection of the medicinal liquid into the needle module.
[0226] Although not shown, the second medical fluid injecting unit 4300 may include all or a part of the same configuration as the driving unit, the storage unit, and the needle module included in the first medical fluid injecting unit 4200.
[0227] The drug solution control infusion device of the present embodiment can measure the blood glucose of the user at least multiple times via the blood glucose measuring unit, or can perform periodic or irregular continuous blood glucose measurement as an optional embodiment. As a specific example, real-time blood glucose measurement can be performed.
[0228] Using the user's blood glucose information measured by such a blood glucose measuring section, the first and second liquid drug injectors of the liquid drug control injection device can selectively inject the first or second liquid drug.
[0229] As a result, a user, for example a user who has difficulty controlling blood sugar, can easily achieve precise blood sugar control through the drug solution control injection device.
[0230] Furthermore, the first or second liquid medicine injector may include a storage unit for storing the liquid medicine, a needle module formed to inject the liquid medicine into an injection target, and a drive unit for driving the movement of the liquid medicine. With this configuration, smooth injection of the first or second liquid medicine can be easily implemented. Also, energy for driving the drive unit can be easily supplied to the drive unit through the power supply unit, thereby maintaining smooth operation of the liquid medicine control injection device.
[0231] As a result, the medicinal liquid control injection device of this embodiment enhances convenience for the user and enables precise control of the injection of the first and second medicinal liquids, thereby enabling precise control of the user's blood sugar.
[0232] FIG. 10 is a schematic diagram for illustrating a drug liquid control injection device relating to yet another embodiment of the present invention, FIG. 11 is an oblique view showing an example of a first drug liquid injection section of FIG. 10, FIG. 12 is a schematic front view of the first drug liquid injection section of FIG. 11, and FIG. 13 is a schematic plan view of the first drug liquid injection section of FIG. 11.
[0233] 10 to 13, a liquid medicine injection device 5500 of the present embodiment may include a blood glucose measuring section 5100, a first liquid medicine injection section 5200, and a second liquid medicine injection section 5300. In the embodiment shown in FIG.
[0234] Although not shown, as an optional embodiment, the drug solution injection device 5500 of this embodiment may further include a housing (not shown) as described in the previous embodiment.
[0235] The blood glucose measuring section 5100 can be configured to measure the user's blood glucose at least sequentially multiple times.
[0236] As an optional embodiment, the blood glucose measurement unit 5100 can measure the user's blood glucose continuously at periodic or irregular intervals for at least a set period of time, and can include, for example, a continuous glucose monitoring (CGM).
[0237] 13, the blood glucose measuring unit 5100 can be formed so as to be included in the first liquid medicine injecting unit 5200. For example, the blood glucose measuring unit 5100 can be formed so as to be covered with a cover 5201 on the inside of the housing of the first liquid medicine injecting unit 5200.
[0238] The first medical solution injecting unit 5200 may include a cover 5201 , which may be configured to cover the storage unit 5210 , the driving unit 5220 , and the needle module 5230 .
[0239] For ease of explanation, FIG. 13 shows a state in which the cover 5201 of FIG. 11 has been removed.
[0240] The first medical solution injecting portion 5200 may include a base 5202 , and the base 5202 may be formed to face the cover 5201 .
[0241] As an optional embodiment, the cover 5201 and the base 5202 may be coupled to each other to form a housing for the first medical fluid injecting portion 5200 .
[0242] In an optional embodiment, the cover 5201 can include an opening, with a button 5235 positioned to correspond to such opening, said button 5235 can correspond to a needle module 5230 .
[0243] For example, a button 5235 can be disposed on the needle module 5230 and the button 5235 can be configured to allow a user to press or rotate the button 5235. Movement relative to the needle module 5230 is possible through the button 5235.
[0244] The first medicinal liquid injecting unit 5200 may be configured to inject a first medicinal liquid containing an ingredient for controlling a decrease in blood glucose of the user, reflecting the blood glucose information measured by the blood glucose measuring unit 5100, to the user.
[0245] For example, the first medicinal liquid injected into the user via the first medicinal liquid injecting section 5200 may include insulin.
[0246] As an optional embodiment, the first medical fluid injecting section 5200 may include a reservoir 5210 for storing the first medical fluid.
[0247] The reservoir 5210 includes one or more outer portions 5211 and can contain a first medical fluid in an interior space formed inside the outer portions 5211 .
[0248] The storage unit 5210 may include a storage space in the form of a tank for storing the liquid medicine. The storage unit 5210 may include a waterproof material capable of storing the liquid medicine, such as a plastic material, or may be formed of various other materials. For example, the storage unit 5210 may include a glass, metal, or silicon material.
[0249] Also, although not shown, the storage portion 5210 may include one or more moving members (not shown) in the space inside the outer portion 5211 where the medicinal liquid is contained, and such moving members enable the first medicinal liquid to move effectively, specifically, to easily transmit the medicinal liquid contained in the storage portion 5210 to the needle module 5230 described later.
[0250] Although not shown, the reservoir 5210 may also include a filling passage (not shown) through which the drug solution may be replenished.
[0251] Also, as an optional embodiment, the first medical fluid injector 5200 can include a module, for example a needle module 5230, for injecting the first medical fluid into the user.
[0252] The needle module 5230 may include at least one needle portion ND. The needle portion ND is hollow, and the first medicinal liquid in the reservoir 5210 may be injected into the injection target through the internal space.
[0253] A connection part TN may be disposed between the needle module 5230 and the reservoir 5210. The connection part TN may include a transfer region such that at least the first medicinal solution in the reservoir 5210 is transferred to the needle module 5230, and may include, for example, a hollow tube shape.
[0254] The connector TN can be formed in various forms, including, for example, a flexible tube form.
[0255] Through such a needle module 5230, the first medical liquid can be easily injected into the inside of the user's skin.
[0256] As an optional embodiment, the first medical fluid injecting unit 5200 can include a driver 5220 for transferring the first medical fluid from the reservoir to the needle module.
[0257] The driving unit 5220 enables the first medicinal liquid stored in the storage unit 5210 to be transferred to the needle module 5230, so that the first medicinal liquid can be easily injected from the needle module 5230 into the target for medicinal liquid injection, for example, the inside of a person's skin.
[0258] As an alternative embodiment, the driving unit 5220 may include a pump, and the first medicinal liquid stored in the reservoir 5210 may be transferred in a predetermined amount toward the needle module 5230 through pumping of the pump.
[0259] The driving unit 5220 may be connected to a power supply unit 5250, which may include a battery and may have various types of forms such as a disposable battery or a rechargeable battery.
[0260] As an alternative embodiment, the driving unit 5220 may be electrically connected to a controller (not shown) and may control the injection of the first medicinal liquid through the control of the controller.
[0261] The driving unit 5220 may be any type of pump having a liquid suction force and a liquid discharge force by electricity. For example, any type of pump such as a mechanical displacement type micropump or an electromagnetic movement type micropump may be used. The mechanical displacement type micropump is a pump that uses the movement of a solid or fluid such as a gear or a diaphragm to generate a pressure difference to induce a fluid flow, and includes a diaphragm displacement pump, a fluid displacement pump, a rotary pump, etc. The electromagnetic movement type micropump is a pump that uses an electric or magnetic form of energy directly to move a fluid, and includes an electrohydrodynamic pump (EHD), an electroosmotic pump, a magnetohydrodynamic pump, an electrowetting pump, etc.
[0262] The driving part 5220 of this embodiment is connected to the storage part 5210, so that the first medicinal liquid contained in the storage part 5210 can be easily transferred to the needle module 5230 through the connection part TN.
[0263] As an optional embodiment, a drive connection 5240 can be disposed between the drive portion 5220 and the reservoir portion 5210 .
[0264] The driving connection unit 5240 can receive a driving force from the driving unit 5220 and transmit the driving force to a moving member (not shown) disposed inside the storage unit 5210. The moving member (not shown) disposed inside the storage unit 5210 can be precisely controlled via the driving connection unit 5240, so that the first medicinal solution in the storage unit 5210 can be precisely controlled and supplied to the needle module 5230.
[0265] For example, the drive connection 5240 can include one or more gear modules.
[0266] The first liquid medicine injecting section 5200 can use the blood glucose information from the blood glucose measuring section 5100 to inject the first liquid medicine once, multiple times, or continuously as necessary.
[0267] As an optional embodiment, if the blood glucose level measured by the blood glucose measuring unit 5100 exceeds a set range, the first medicinal liquid can be injected by the first medicinal liquid injection unit 5200 via the control unit (not shown), for example, the drive unit 5220 can be controlled via the control unit (not shown) to control the injection of the medicinal liquid by the needle module 5230.
[0268] Such a control unit (not shown) can be included in the blood glucose measuring unit 5100, and can be included in the first liquid medicine injecting unit 5200 or the second liquid medicine injecting unit 5300.
[0269] In addition, a control unit (not shown) can be disposed as a separate member.
[0270] As an optional embodiment, the control unit can notify a user or the like of the value measured by the blood glucose measuring unit 5100, and the user can operate the control unit to control the injection of the first liquid medicine injection unit 5200 or the second liquid medicine injection unit 5300.
[0271] The second liquid medicine injecting unit 5300 may be configured to inject a second liquid medicine containing an ingredient for controlling an increase in the blood glucose of the user, reflecting the blood glucose information measured by the blood glucose measuring unit 5100, to the user.
[0272] For example, the second medical fluid infused to the user via second medical fluid infusion section 5300 may include glucagon.
[0273] As an optional embodiment, the second medical fluid injecting section 5300 may include a reservoir (not shown) for storing the second medical fluid.
[0274] Also, as an optional embodiment, the second medicinal liquid injection section 5300 may include a module for injecting the second medicinal liquid into the user, such as a needle module (not shown), and the second medicinal liquid can be easily injected inside the user's skin via such a needle module.
[0275] As an optional embodiment, the second medical fluid injecting unit 5300 may include a driving unit (not shown) that transfers the second medical fluid from the reservoir to the needle module. For example, such a driving unit may include a pump, and a predetermined amount of the second medical fluid may be injected into the user through pumping of the pump.
[0276] The second liquid medicine injecting section 5300 can use the blood glucose information from the blood glucose measuring section 5100 to inject the second liquid medicine once, multiple times, or continuously as necessary.
[0277] As an optional embodiment, the blood glucose measuring section 5100 and the second liquid medicine injecting section 5300 may include a communication section NW for transmitting information by wire or wirelessly.
[0278] As an optional embodiment, when the blood glucose level measured by the blood glucose measuring unit 5100 falls below a set range, the second medicinal liquid can be injected by the second medicinal liquid injection unit 5300 via the control unit (not shown), for example, by controlling the drive unit to control the injection of the medicinal liquid into the needle module.
[0279] Although not shown, the second medical fluid injecting unit 5300 may include all or a part of the same configuration as the driving unit, the storage unit, and the needle module included in the first medical fluid injecting unit 5200.
[0280] The drug solution control infusion device of the present embodiment can measure the blood glucose of the user at least multiple times via the blood glucose measuring unit, or can perform periodic or irregular continuous blood glucose measurement as an optional embodiment. As a specific example, real-time blood glucose measurement can be performed.
[0281] Using the user's blood glucose information measured by such a blood glucose measuring section, the first and second liquid drug injectors of the liquid drug control injection device can selectively inject the first or second liquid drug.
[0282] As a result, a user, for example a user who has difficulty controlling blood sugar, can easily achieve precise blood sugar control through the drug solution control injection device.
[0283] Furthermore, the first or second liquid medicine injector may include a storage unit for storing the liquid medicine, a needle module formed to inject the liquid medicine into an injection target, and a drive unit for driving the movement of the liquid medicine. With this configuration, smooth injection of the first or second liquid medicine can be easily implemented. Also, energy for driving the drive unit can be easily supplied to the drive unit through the power supply unit, thereby maintaining smooth operation of the liquid medicine control injection device.
[0284] The blood glucose measuring unit can be included in the first liquid medicinal fluid injecting unit, or can be formed to include at least one region thereof, thereby improving the convenience of handling and management of the blood glucose measuring unit and the first liquid medicinal fluid injecting unit.
[0285] Although not shown, the blood glucose measuring section may be included in the second liquid medicine injecting section, or may be formed so as to include at least one region thereof.
[0286] As an alternative embodiment, the device may include a drive connector connected to the drive unit, and the moving unit inside the reservoir may be precisely controlled via the drive connector, thereby precisely controlling the supply amounts of the first and second liquid medicines.
[0287] As a result, the medicinal liquid control injection device of this embodiment enhances convenience for the user and enables precise control of the injection of the first and second medicinal liquids, thereby enabling precise control of the user's blood sugar.
[0288] FIG. 14 is a schematic diagram illustrating a drug solution control injection device according to still another embodiment of the present invention.
[0289] 14, a liquid medicine injection device 6500 of this embodiment may include a blood glucose measuring section 6100, a first liquid medicine injection section 6200, a second liquid medicine injection section 6300, and a housing 6510.
[0290] The housing 6510 can have a unitary form, for example, a box shape.
[0291] In an alternative embodiment, the housing 6510 can have a configuration that includes a separate base and cover.
[0292] A part or the entire area of the blood glucose measuring section 6100, the first medical fluid injecting section 6200, and the second medical fluid injecting section 6300 may be covered by a housing 6510.
[0293] For example, a cover (not shown) of the housing 6510 may have a configuration in which the blood glucose measuring section 6100, the first liquid medicine injecting section 6200, and the second liquid medicine injecting section 6300 are partially or entirely covered.
[0294] The blood glucose measuring unit 6100 can be configured to measure the user's blood glucose at least sequentially multiple times.
[0295] As an optional embodiment, the blood glucose measurement unit 6100 can measure the user's blood glucose continuously at periodic or irregular intervals for at least a set period of time, and can include, for example, a continuous glucose monitoring device (CGM).
[0296] The first medical solution injecting unit 6200 may include a first storage unit 6210, a first driving unit 6220, and a first needle module 6230.
[0297] The first medicinal liquid injecting unit 6200 may be configured to inject a first medicinal liquid containing an ingredient for controlling a decrease in blood glucose of the user, reflecting the blood glucose information measured by the blood glucose measuring unit 6100, to the user.
[0298] For example, the first medicinal liquid injected into the user via the first medicinal liquid injecting section 6200 may include insulin.
[0299] As an optional embodiment, the first medical fluid injecting section 6200 may include a first storage section 6210 for storing the first medical fluid.
[0300] The first storage unit 6210 may be any one of the storage units described in the above embodiments, and therefore a detailed description thereof will be omitted.
[0301] As an optional embodiment, the first medical fluid injector 6200 may include a module, such as a first needle module 6230, for injecting the first medical fluid into the user.
[0302] The first needle module 6230 may include at least one needle portion ND. The needle portion ND is hollow, and the first medicinal liquid in the first storage portion 6210 may be injected into the injection target through the internal space.
[0303] The first needle module 6230 may selectively employ any one of the needle modules described in the above embodiments, and therefore a detailed description thereof will be omitted.
[0304] As an optional embodiment, the first medical fluid injecting unit 6200 may include a first actuator 6220 for transferring the first medical fluid from the reservoir to the needle module.
[0305] The first driving unit 6220 may be connected to a power supply unit (not shown).
[0306] The first driving unit 6220 may selectively use any one of the driving units described in the above embodiments, and therefore a detailed description thereof will be omitted.
[0307] The first liquid medicine injecting section 6200 can use the blood glucose information from the blood glucose measuring section 6100 to inject the first liquid medicine once, multiple times, or continuously as necessary.
[0308] As an optional embodiment, if the blood glucose level measured by the blood glucose measuring unit 6100 exceeds a set range, the first medicinal liquid can be injected by the first medicinal liquid injection unit 6200 via the control unit (not shown), for example, the first drive unit 6220 can be controlled via the control unit (not shown) to control the injection of the medicinal liquid by the first needle module 6230.
[0309] Such a control unit (not shown) can be included in the blood glucose measuring unit 6100, and can be included in the first liquid medicine injecting unit 6200 or the second liquid medicine injecting unit 6300.
[0310] In addition, a control unit (not shown) can be disposed as a separate member.
[0311] As an optional embodiment, the control unit can notify a user or the like of the value measured by the blood glucose measuring unit 6100, and the user can operate the control unit to control the injection of the first liquid medicine injection unit 6200 or the second liquid medicine injection unit 6300.
[0312] The second medical solution injecting unit 6300 may include a second storage unit 6310, a second driving unit 6320, and a second needle module 6330.
[0313] The blood glucose measuring unit 6100 may be configured to inject a second liquid medicine containing an ingredient for controlling an increase in the blood glucose of the user, to the user, based on the blood glucose information measured by the blood glucose measuring unit 6100.
[0314] For example, the second medical fluid infused to the user via the second medical fluid infusion section 6300 can include glucagon.
[0315] The second medicinal liquid injecting section 6300 may include a second storage section 6310 that stores a second medicinal liquid.
[0316] Also, as an optional embodiment, the second medicinal liquid injection section 6300 may include a module for injecting the second medicinal liquid into the user, for example, a second needle module 6330, and the second medicinal liquid can be easily injected inside the user's skin through such a needle module.
[0317] As an optional embodiment, the second medical fluid injecting unit 6300 may include a second actuator 6320 that transfers the second medical fluid from the second reservoir 6310 to the second needle module 6330 .
[0318] The second liquid medicine injecting section 6300 can use the blood glucose information from the blood glucose measuring section 6100 to inject the second liquid medicine once, multiple times, or continuously as necessary.
[0319] As an optional embodiment, the blood glucose measuring unit 6100 and the second liquid medicine injecting unit 6300 may include a communication unit for transmitting information by wire or wirelessly.
[0320] As an optional embodiment, when the blood glucose level measured by the blood glucose measuring unit 6100 falls below a set range, the second medicinal liquid can be injected by the second medicinal liquid injection unit 6300 via the control unit (not shown), for example, by controlling the second drive unit 6320 to control the injection of the medicinal liquid into the needle module.
[0321] Although not shown, the second medical fluid injecting unit 6300 may include all or part of the same components as the drive unit, storage unit, and needle module included in the first medical fluid injecting unit 6200.
[0322] The drug solution control infusion device of the present embodiment can measure the blood glucose of the user at least multiple times via the blood glucose measuring unit, or can perform periodic or irregular continuous blood glucose measurement as an optional embodiment. As a specific example, real-time blood glucose measurement can be performed.
[0323] Using the user's blood glucose information measured by such a blood glucose measuring section, the first and second liquid drug injectors of the liquid drug control injection device can selectively inject the first or second liquid drug.
[0324] As a result, a user, for example a user who has difficulty controlling blood sugar, can easily achieve precise blood sugar control through the drug solution control injection device.
[0325] Furthermore, the first or second liquid medicine injector may include a storage unit for storing the liquid medicine, a needle module formed to inject the liquid medicine into an injection target, and a drive unit for driving the movement of the liquid medicine. With this configuration, smooth injection of the first or second liquid medicine can be easily implemented. Also, energy for driving the drive unit can be easily supplied to the drive unit through the power supply unit, thereby maintaining smooth operation of the liquid medicine control injection device.
[0326] The blood glucose measuring unit, the first liquid medicinal fluid injecting unit, and the second liquid medicinal fluid injecting unit may be included in a housing, and at least one area of the blood glucose measuring unit, the first liquid medicinal fluid injecting unit, and the second liquid medicinal fluid injecting unit may be covered by a housing cover. As a specific example, the blood glucose measuring unit, the first liquid medicinal fluid injecting unit, and the second liquid medicinal fluid injecting unit may be integrated into one body. This can improve the convenience of handling and management of the liquid medicinal fluid control and injection device including the blood glucose measuring unit, the first liquid medicinal fluid injecting unit, and the second liquid medicinal fluid injecting unit.
[0327] As a result, the medicinal liquid control injection device of this embodiment enhances convenience for the user and enables precise control of the injection of the first and second medicinal liquids, thereby enabling precise control of the user's blood sugar.
[0328] FIG. 15 is a schematic diagram illustrating a drug solution control injection device according to still another embodiment of the present invention.
[0329] The housing 7510 can have a unitary form, for example, a box shape.
[0330] In an alternative embodiment, the housing 7510 can have a configuration that includes a separate base and cover.
[0331] A part or the entire area of the blood glucose measuring section 7100, the first medical fluid injecting section 7200, and the second medical fluid injecting section 7300 can be covered by a housing 7510.
[0332] For example, the cover (not shown) of the housing 7510 may have a configuration in which the blood glucose measuring section 7100, the first liquid medicine injecting section 7200, and the second liquid medicine injecting section 7300 are partially or entirely covered.
[0333] The blood glucose measuring unit 7100 can be configured to measure the user's blood glucose at least sequentially multiple times.
[0334] As an optional embodiment, the blood glucose measurement unit 7100 can measure the user's blood glucose continuously at periodic or irregular intervals for at least a set period of time, and can include, for example, a continuous glucose monitoring device (CGM).
[0335] The first medical solution injecting unit 7200 may include a first storage unit 7210, a first driving unit 7220, and a common needle module 7530.
[0336] The first medicinal liquid injecting unit 7200 may be configured to inject a first medicinal liquid containing an ingredient for controlling a decrease in blood glucose of the user, reflecting the blood glucose information measured by the blood glucose measuring unit 7100, to the user.
[0337] For example, the first medicinal liquid injected into the user via the first medicinal liquid injecting section 7200 may include insulin.
[0338] As an optional embodiment, the first medical fluid injecting section 7200 may include a first storage section 7210 for storing the first medical fluid.
[0339] The first storage unit 7210 may be any one of the storage units described in the above embodiments, and therefore a detailed description thereof will be omitted.
[0340] Also, as an optional embodiment, the first medical fluid injector 7200 can include a module for injecting the first medical fluid into the user, such as a common needle module 7530.
[0341] The common needle module 7530 may include at least one needle portion ND. The needle portion ND is hollow, and the first medicinal liquid in the first storage portion 7210 may be injected into the injection target through the internal space.
[0342] As an optional embodiment, the first medical fluid injecting unit 7200 may include a first actuator 7220 for transferring the first medical fluid from the reservoir to the needle module.
[0343] The first driving unit 7220 may be connected to a power supply unit (not shown).
[0344] *The first driving unit 7220 may selectively use any one of the driving units described in the above embodiments, so a detailed description thereof will be omitted.
[0345] The first liquid medicine injecting section 7200 can use the blood glucose information from the blood glucose measuring section 7100 to inject the first liquid medicine once, multiple times, or continuously as necessary.
[0346] As an optional example, if the blood glucose level measured by the blood glucose measuring unit 7100 exceeds a set range, the first medicinal liquid can be injected by the first medicinal liquid injection unit 7200 via the control unit (not shown), for example, the first drive unit 7220 can be controlled via the control unit (not shown) to control the injection of medicinal liquid by the common needle module 7530.
[0347] Such a control unit (not shown) can be included in the blood glucose measuring unit 7100, and can be included in the first liquid medicine injecting unit 7200 or the second liquid medicine injecting unit 7300.
[0348] In addition, a control unit (not shown) can be disposed as a separate member.
[0349] As an optional example, the control unit can notify a user or the like of the value measured by the blood glucose measuring unit 7100, and the user can operate the control unit to control the injection of the first liquid medicine injection unit 7200 or the second liquid medicine injection unit 7300.
[0350] The second medical fluid injecting unit 7300 may include a second reservoir 7310, a second actuator 7320, and a common needle module 7530.
[0351] The blood glucose measuring unit 7100 may be configured to inject a second liquid medicine containing an ingredient for controlling an increase in the user's blood glucose, based on the blood glucose information measured by the blood glucose measuring unit 7100, into the user.
[0352] For example, the second medical fluid infused to the user via second medical fluid infusion section 7300 may include glucagon.
[0353] The second medical fluid injecting section 7300 may include a second storage section 7310 that stores a second medical fluid.
[0354] Also, as an optional example, the second medicinal liquid injection section 7300 may include a module for injecting the second medicinal liquid into the user, such as a common needle module 7530, and the second medicinal liquid may be easily injected inside the user's skin via such a needle module.
[0355] As an optional example, the second medical fluid injector 7300 can include a second actuator 7320 to deliver a second medical fluid from the second reservoir 7310 to the common needle module 7530 .
[0356] The second liquid medicine injecting section 7300 can use the blood glucose information from the blood glucose measuring section 7100 to inject the second liquid medicine once, multiple times, or continuously as necessary.
[0357] As an optional embodiment, the blood glucose measuring unit 7100 and the second liquid medicine injecting unit 7300 may include a communication unit for transmitting information by wire or wirelessly.
[0358] As an optional embodiment, when the blood glucose level measured by the blood glucose measuring unit 7100 falls below a set range, the second medicinal liquid can be injected by the second medicinal liquid injection unit 7300 via the control unit (not shown), for example, by controlling the second drive unit 7320 to control the injection of the medicinal liquid into the needle module.
[0359] Although not shown, the second medical fluid injecting unit 7300 may include all or a part of the same configuration as the driving unit, the storage unit, and the needle module included in the first medical fluid injecting unit 7200.
[0360] This embodiment includes a common needle module 7530 for injection of a first medical fluid and injection of a second medical fluid.
[0361] The common needle module 7530 is connected to a first storage unit 7210 storing a first medical liquid and a second storage unit 7310 storing a second medical liquid, so that the first medical liquid and the second medical liquid can be selectively supplied. For example, the first medical liquid can be supplied through the first storage unit 7210 and the second medical liquid can be selectively supplied through the second storage unit 7310 by the valve VL.
[0362] This makes it possible to easily inject a desired one of the first and second medicinal liquids selectively into the injection target via the common needle module 7530.
[0363] The drug solution control infusion device of the present embodiment can measure the blood glucose of the user at least multiple times via the blood glucose measuring unit, or can perform periodic or irregular continuous blood glucose measurement as an optional embodiment. As a specific example, real-time blood glucose measurement can be performed.
[0364] Using the user's blood glucose information measured by such a blood glucose measuring section, the first and second liquid drug injectors of the liquid drug control injection device can selectively inject the first or second liquid drug.
[0365] As a result, a user, for example a user who has difficulty controlling blood sugar, can easily achieve precise blood sugar control through the drug solution control injection device.
[0366] In addition, the first liquid medicine injector or the second liquid medicine injector may include a storage unit that stores the liquid medicine and a drive unit that drives the movement of the liquid medicine, thereby making it possible to maintain smooth operation of the liquid medicine control injection device.
[0367] Meanwhile, the device may include a common needle module formed to inject a medicinal liquid into an injection target, and the common needle module may be connected to a first storage unit storing a first medicinal liquid and a second storage unit storing a second medicinal liquid. Also, by controlling a valve or the like, one of the first and second medicinal liquids may be selectively injected into the injection target through the common needle module as needed.
[0368] For example, when it is necessary to lower blood glucose levels, the valve is controlled to close the connection to the second storage unit, a first medicinal liquid is supplied, and the common needle module injects the first medicinal liquid into the subject, and when it is necessary to increase blood glucose levels, the valve is controlled to close the connection to the first storage unit, a second medicinal liquid is supplied, and the common needle module injects the second medicinal liquid into the subject.
[0369] This allows the common needle module to be applied commonly to the first drug solution injection section and the second drug solution injection section, thereby reducing the space required for arranging the needle module, increasing the design freedom of the space in the entire housing, and reducing the energy required for controlling the needle module.
[0370] This makes it possible to improve the convenience of handling and management of the drug solution controlling and injecting device including the blood glucose measuring unit, the first drug solution injector, and the second drug solution injector.
[0371] As a result, the medicinal liquid control injection device of this embodiment enhances convenience for the user and enables precise control of the injection of the first and second medicinal liquids, thereby enabling precise control of the user's blood sugar.
[0372] FIG. 16 is a schematic diagram illustrating a drug solution control injection device according to still another embodiment of the present invention.
[0373] 16, a liquid medicine injection device 8500 of this embodiment may include a blood glucose measuring section 8100, a first liquid medicine injection section 8200, a second liquid medicine injection section 8300, and a housing 8510.
[0374] The housing 8510 can have a unitary form, for example, a box shape.
[0375] In an alternative embodiment, the housing 8510 can have a configuration that includes a separate base and cover.
[0376] A part or the entire area of the blood glucose measuring section 8100, the first medical fluid injecting section 8200, and the second medical fluid injecting section 8300 can be covered by a housing 8510.
[0377] For example, the cover (not shown) of the housing 8510 may have a configuration in which the blood glucose measuring section 8100, the first liquid medicine injecting section 8200, and the second liquid medicine injecting section 8300 are partially or entirely covered.
[0378] The blood glucose measuring unit 8100 can be configured to measure the user's blood glucose at least sequentially multiple times.
[0379] As an optional embodiment, the blood glucose measurement unit 8100 can measure the user's blood glucose continuously at periodic or irregular intervals for at least a set period of time, and can include, for example, a continuous glucose monitoring (CGM).
[0380] The first medical solution injecting unit 8200 may include a first storage unit 8210 , a common driving unit 8520 , and a first needle module 8230 .
[0381] The first medicinal liquid injecting unit 8200 may be configured to inject a first medicinal liquid, which includes an ingredient for controlling a decrease in blood glucose of the user, into the user, in response to blood glucose information measured by the blood glucose measuring unit 8100 .
[0382] For example, the first medicinal liquid injected into the user via the first medicinal liquid injecting section 8200 can include insulin.
[0383] As an optional embodiment, the first medical fluid injecting section 8200 may include a first storage section 8210 that stores the first medical fluid.
[0384] The first storage unit 8210 may be any one of the storage units described in the above embodiments, and therefore a detailed description thereof will be omitted.
[0385] Also, as an optional embodiment, the first medical fluid injector 8200 may include a module for injecting the first medical fluid into the user, for example, a first needle module 8230.
[0386] The first needle module 8230 may include at least one needle portion ND. The needle portion ND is hollow, and the first medicinal liquid in the first storage portion 8210 may be injected into the injection target through the internal space.
[0387] The first needle module 8230 may selectively employ any one of the needle modules described in the above embodiments, and therefore a detailed description thereof will be omitted.
[0388] As an optional embodiment, the first medical fluid injector 8200 can include a common driver 8520 for transferring the first medical fluid from the reservoir to the needle module.
[0389] The common driver 8520 may be connected to a power supply (not shown).
[0390] The common driving unit 8520 may selectively include any one of the configurations of the driving units described in the above embodiments, and may include, for example, a pump unit.
[0391] The first liquid medicine injecting section 8200 can use the blood glucose information from the blood glucose measuring section 8100 to inject the first liquid medicine once, multiple times, or continuously as necessary.
[0392] As an optional embodiment, if the blood glucose level measured by the blood glucose measuring unit 8100 exceeds a set range, the first medicinal liquid can be injected by the first medicinal liquid injection unit 8200 via the control unit (not shown), for example, the common drive unit 8520 can be controlled via the control unit (not shown) to control the injection of the medicinal liquid by the first needle module 8230.
[0393] Such a control unit (not shown) can be included in the blood glucose measuring unit 8100, and can be included in the first liquid medicine injecting unit 8200 or the second liquid medicine injecting unit 8300.
[0394] In addition, a control unit (not shown) can be disposed as a separate member.
[0395] As an optional embodiment, the control unit can notify a user or the like of the value measured by the blood glucose measuring unit 8100, and the user can operate the control unit to control the injection of the first liquid medicine injection unit 8200 or the second liquid medicine injection unit 8300.
[0396] The second medical fluid injecting unit 8300 may include a second storage unit 8310, a common driving unit 8520, and a second needle module 8330.
[0397] The blood glucose measuring unit 8100 may be configured to inject a second liquid medicine containing an ingredient for controlling an increase in the user's blood glucose, based on the blood glucose information measured by the blood glucose measuring unit 8100, into the user.
[0398] For example, the second medical fluid infused to the user via second medical fluid infusion section 8300 may include glucagon.
[0399] The second medicinal liquid injecting section 8300 may include a second storage section 8310 that stores a second medicinal liquid.
[0400] Also, as an optional embodiment, the second medicinal liquid injection section 8300 may include a module for injecting the second medicinal liquid into the user, for example, a second needle module 8330, and the second medicinal liquid can be easily injected inside the user's skin through such a needle module.
[0401] As an optional embodiment, the second medical fluid injecting unit 8300 may include a common driver 8520 for transferring the second medical fluid from the second reservoir 8310 to the second needle module 8330 .
[0402] The second liquid medicine injecting section 8300 can use the blood glucose information from the blood glucose measuring section 8100 to inject the second liquid medicine once, multiple times, or continuously as necessary.
[0403] As an optional embodiment, the blood glucose measuring section 8100 and the second liquid medicine injecting section 8300 may include a communication section for transmitting information by wire or wirelessly.
[0404] As an optional embodiment, when the blood glucose level measured by the blood glucose measuring unit 8100 falls below a set range, the second medicinal liquid can be injected by the second medicinal liquid injection unit 8300 via the control unit (not shown), for example, by controlling the common drive unit 8520 to control the injection of the medicinal liquid into the needle module.
[0405] Although not shown, the second medical fluid injecting unit 8300 may include all or a part of the same configuration as the driving unit, the storage unit, and the needle module included in the first medical fluid injecting unit 8200.
[0406] This embodiment includes a common driving unit 8520 that transmits a driving force to supply the first medicinal liquid in the first storage unit 8210 to the first needle module 8230, and transmits a driving force to supply the second medicinal liquid in the second storage unit 8310 to the second needle module 8330.
[0407] The common driving unit 8520 is connected to a first storage unit 8210 in which a first medicinal liquid is stored and a second storage unit 8310 in which a second medicinal liquid is stored, thereby being able to selectively control whether the first medicinal liquid is supplied to the first needle module 8230 or the second medicinal liquid is supplied to the second needle module 8330.
[0408] This makes it possible to easily inject a desired one of the first and second medicinal liquids selectively into the injection target through the control of the common drive unit 8520.
[0409] The drug solution control infusion device of the present embodiment can measure the blood glucose of the user at least multiple times via the blood glucose measuring unit, or can perform periodic or irregular continuous blood glucose measurement as an optional embodiment. As a specific example, real-time blood glucose measurement can be performed.
[0410] Using the user's blood glucose information measured by such a blood glucose measuring section, the first and second liquid drug injectors of the liquid drug control injection device can selectively inject the first or second liquid drug.
[0411] As a result, a user, for example a user who has difficulty controlling blood sugar, can easily achieve precise blood sugar control through the drug solution control injection device.
[0412] Furthermore, the first or second liquid medicine injector may include a storage unit for storing the liquid medicine, a needle module formed to inject the liquid medicine into an injection target, and a drive unit for driving the movement of the liquid medicine. With this configuration, smooth injection of the first or second liquid medicine can be easily implemented. Also, energy for driving the drive unit can be easily supplied to the drive unit through the power supply unit, thereby maintaining smooth operation of the liquid medicine control injection device.
[0413] Meanwhile, the device may include a common driving unit connected to the first storage unit and the second storage unit to selectively provide a driving force, and may control the common driving unit to selectively transfer the first medical liquid in the first storage unit to the first needle module or transfer the second medical liquid in the second storage unit to the second needle module as necessary, thereby injecting one of the first and second medical liquids into an injection target.
[0414] For example, when it is necessary to lower blood sugar levels, the drive control unit controls the driving force to be transmitted to the first storage unit without transmitting the driving force to the second storage unit, and the first medicinal liquid in the first storage unit is supplied to the first needle module to inject the first medicinal liquid into the injection target, and when it is necessary to increase blood sugar levels, the drive control unit controls the driving force to be transmitted to the second storage unit without transmitting the driving force to the first storage unit, and the second medicinal liquid in the second storage unit is supplied to the second needle module to inject the second medicinal liquid into the injection target.
[0415] This allows the common drive unit to be used in common for both the first and second drug solution injection units, reducing the space required for arranging the drive units, increasing the design freedom of the space in the entire housing, and reducing the energy required to control the drive units.
[0416] The blood glucose measuring unit, the first liquid medicinal fluid injecting unit, and the second liquid medicinal fluid injecting unit may be included in a housing, and at least one area of the blood glucose measuring unit, the first liquid medicinal fluid injecting unit, and the second liquid medicinal fluid injecting unit may be covered by a housing cover. As a specific example, the blood glucose measuring unit, the first liquid medicinal fluid injecting unit, and the second liquid medicinal fluid injecting unit may be integrated into one body. This can improve the convenience of handling and management of the liquid medicinal fluid control and injection device including the blood glucose measuring unit, the first liquid medicinal fluid injecting unit, and the second liquid medicinal fluid injecting unit.
[0417] As a result, the medicinal liquid control injection device of this embodiment enhances convenience for the user and enables precise control of the injection of the first and second medicinal liquids, thereby enabling precise control of the user's blood sugar.
[0418] FIG. 17 is a diagram showing one alternative embodiment of a drive unit included in a drug solution control injection device according to yet another embodiment of the present invention.
[0419] For example, FIG. 17 shows a pump unit 120 that can be applied to either a first drive unit of a first drug solution injection unit, a second drive unit of a second drug solution injection unit, or a common drive unit that is commonly applied, included in a drug solution control injection device.
[0420] Specifically, such a pump unit 120 and the pump units described in the embodiments described below can be applied directly to at least one of the first driving unit, the second driving unit, and the common driving unit of the above-mentioned embodiments, or can be applied in part or with some modifications as necessary.
[0421] 17, the housing 110 of the pump unit 120 includes a shaft hole 112H provided on one side, and a shaft 130 having a predetermined length may extend to the outside of the housing 110 through the shaft hole 112H. As an embodiment, the shaft hole 112H may be formed in a protrusion 112 extending to one side of the main body 111 of the housing 110, and the diameter of the protrusion 112 may be smaller than the diameter of the main body 111.
[0422] The first portion 131 of the shaft 130 is disposed inside the housing 110, and the second portion 132 may extend to the outside of the housing 110 through the shaft hole 112H. The shaft 130 may reciprocate along the vertical direction (z direction) of FIG. 17. When the shaft 130 reciprocates, the first portion 131 may linearly reciprocate in the internal space of the housing 110, for example, the internal space corresponding to the protrusion 112. Since the diameter R1 of the first portion 131 of the shaft 130 is larger than the diameter R3 of the shaft hole 112H, the first portion 131 may not slip out of the housing 110.
[0423] As an alternative embodiment, the second portion 132 of the shaft 130 may have a diameter R2 smaller than the diameter R3 of the shaft hole 112H. In this case, the second portion 132 may be coupled to a movement control portion 113 disposed outside the housing 110 to prevent the second portion 132 from slipping out of the shaft hole 112H.
[0424] A sealant 125 may be disposed on a side surface of the first portion 131 of the shaft 130. The internal space of the housing 110, for example, a space defined by the inner surface of the housing 110 and the inner surface of the shaft 130, is a sealed space in which a fluid exists, and the sealant 125 may restrict leakage (leakage) of the fluid into a gap between the housing 110 and the shaft 130. For convenience of explanation, the fluid is omitted in FIG. 17.
[0425] 17, the seal 125 may cover the side surface of the first portion 131 in the form of an O-ring, and the seal 125 may prevent the fluid present inside the housing 110 from leaking (leaking) to the outside of the housing 110 through the shaft hole 112H. The leakage of the fluid may be more effectively restricted by forming the first distance D1 from the first portion 131 of the shaft 120 to the movement control portion 113 to be equal to or smaller than the inner length D2 of the protrusion 112.
[0426] The membrane 140 may be disposed in an internal space of the housing 110, for example, an internal space corresponding to the main body 111. The internal space includes a first space S1 and a second space S2 located on both sides of the membrane 140. In Fig. 17, the space farther from the shaft 130 with respect to the membrane 140 as the reference is shown as the first space S1, and the space adjacent to the shaft 130 with respect to the membrane 140 as the reference is shown as the second space S2.
[0427] The membrane 140 may have a porous structure that allows the movement of fluids and ions. The membrane 140 may be, for example, a frit membrane manufactured by sintering spherical silica with heat. For example, the spherical silica used to form the membrane may have a diameter of about 20 nm to about 500 nm, specifically, about 30 nm to about 300 nm, and more specifically, about 40 nm to about 200 nm. When the diameter of the spherical silica satisfies the above-mentioned range, the pressure due to the first fluid passing through the membrane 140, i.e., a pressure sufficient to move the shaft 130, can be generated.
[0428] Although the membrane 140 has been described as including spherical silica, the membrane 140 is not limited thereto. In another embodiment, the membrane 140 is not limited to a specific type as long as it is made of a material that can cause an electrokinetic phenomenon due to a zeta potential, such as porous silica or porous alumina.
[0429] Membrane 140 can have a thickness of about 20 μm to about 10 mm, specifically, about 300 μm to about 5 mm, and more specifically, about 1,000 μm to about 4 mm.
[0430] A first electrode body 150 and a second electrode body 160 are disposed on either side of the membrane 140. The first electrode body 150 may include a first porous plate 151 and a first electrode strip 152 disposed on a first side of the membrane 140. The second electrode body 160 may include a second porous plate 161 and a second electrode strip 162 disposed on a second side of the membrane 140.
[0431] The first and second porous plates 151 and 161 may be disposed to contact both main surfaces of the membrane 140, respectively. The first and second porous plates 151 and 161 may effectively move fluids and ions through a porous structure. The first and second porous plates 151 and 161 may have a structure in which an electrochemical reactant is formed on a porous base layer. The electrochemical reactant may be formed by electrodeposition or coating on the porous base layer by a method such as electroless plating, vacuum deposition, coating, or a sol-gel process.
[0432] The porous base layer may be an insulator, for example, the porous base layer may include one or more selected from a non-conductive ceramic, a non-conductive polymeric resin, a non-conductive glass, and combinations thereof.
[0433] The non-conductive ceramic may include, for example, one or more selected from the group consisting of rock wool, gypsum, ceramic, cement, and combinations thereof, and specifically, may include, but is not limited to, one or more selected from the group consisting of rock wool, gypsum, and combinations thereof.
[0434] The non-conductive polymeric resin may include, but is not limited to, one or more selected from the group consisting of synthetic fibers, such as those selected from the group consisting of polypropylene, polyethylene terephthalate, polyacrylonitrile, and combinations thereof; natural fibers, such as those selected from the group consisting of wool, cotton, and combinations thereof; sponges; porous materials derived from living organisms, such as the bones of living organisms; and combinations thereof.
[0435] The non-conductive glass may include, but is not limited to, one or more selected from the group consisting of glass wool, glass frit, porous glass, and combinations thereof.
[0436] The porous base layer may have a pore size of about 0.1 μm to about 500 μm, specifically, about 5 μm to about 300 μm, and more specifically, about 10 μm to about 200 μm. When the pore size of the porous support satisfies the above-mentioned range, the fluid and ions can be effectively transferred, and the stability, life characteristics, and efficiency of the pump unit 120 can be improved.
[0437] The electrochemically reactive material may include a material capable of forming a pair of reactions in which an oxidizing electrode and a reducing electrode exchange cations, such as hydrogen ions, during an electrode reaction of the first and second electrode bodies 150 and 160, and simultaneously forming a reversible electrochemical reaction. The electrochemically reactive material may include, for example, one or more selected from the group consisting of silver / silver oxide, silver / silver chloride, MnO(OH), polyaniline, polypyrrole, polythiophene, polythionine, quinone-based polymer, and combinations thereof.
[0438] The first and second strips 152, 162 may be disposed on edges of the first and second porous plates 151, 161 and may be connected to first and second terminals 153, 163 on the outside of the housing 110. The first and second strips 152, 162 may include a conductive material such as silver, copper, or the like.
[0439] The fluid provided in the internal space of the housing 110 may include a first fluid and a second fluid having different phases. The first fluid may include a liquid such as water, and the second fluid may include a gas such as air. The first fluid present in the internal space does not entirely fill the internal space. That is, the volume of the internal space is larger than the volume of the first fluid present in the internal space. The second fluid is present in the portion of the internal space where no water is present.
[0440] A sealant 117 is disposed on both sides of the structure of the membrane 140, the first electrode body 150, and the second electrode body 160. The sealant 117 may be annular having an area corresponding to the edge of the above-mentioned structure. The above-mentioned fluid, for example, the first fluid, moves from the first space S1 to the second space S2 or vice versa along the thickness direction of the membrane 140 to pass through the membrane 140, and at this time, the sealant 117 can block the gap between the inner surface of the housing 110 and the above-mentioned structure to prevent the liquid from moving through the gap.
[0441] The fluid may be introduced into the internal space through the inlet 118. In one embodiment, the first fluid may be entirely filled into the internal space through the inlets 118 on both sides, and then a portion of the first fluid may be discharged to the outside through any one of the inlets 118, and then the inlet 118 may be closed, so that the first fluid and the second fluid may be present in the internal space of the housing 110.
[0442] Although not shown, the first electrode body 150 and the second electrode body 160 can each be connected to a power source via a terminal, and the polarity of the power source voltage can be alternated to change the movement direction of a liquid such as water.
[0443] Through such control, it is also possible to control the movement of the shaft 130 of the pump unit 120. Through such movement of the shaft 130, it is possible to facilitate precise control of the movement of the first or second chemical liquid in the above-described embodiments.
[0444] FIG. 18 is a diagram showing one alternative embodiment of a drive unit included in a drug solution control injection device according to yet another embodiment of the present invention.
[0445] For example, FIG. 18 shows a pump unit 229 that can be applied to either a first drive unit of a first liquid drug injection unit, a second drive unit of a second liquid drug injection unit, or a common drive unit that is commonly applied, all of which are included in a liquid drug control injection device.
[0446] The pump section 229 in FIG. 18 may be a pump that utilizes electroosmotic pressure.
[0447] Referring to FIG. 18, the housing 210 of the pump part 229 includes a shaft hole 212H provided on one side, and a shaft 220 having a predetermined length can extend to the outside of the housing 210 through the shaft hole 212H.
[0448] In one embodiment, the shaft hole 212H may be formed in a protrusion 212 extending to one side of the body 211 of the housing 210, and the diameter of the protrusion 212 may be smaller than the diameter of the body 211.
[0449] The first portion 221 of the shaft 220 is disposed inside the housing 210, and the second portion 222 extends to the outside of the housing 110 through the shaft hole 112H as described above. The shaft 220 can reciprocate along the up-down direction (Z direction).
[0450] The second portion 222 of the shaft 220 can have a diameter R2 smaller than the diameter R3 of the shaft hole 212H, and as an optional embodiment, the second portion 222 can be coupled to a movement control section 213 disposed outside the housing 210.
[0451] A sealant 225 may be disposed on a side surface of the first portion 221 of the shaft 220 .
[0452] The membrane 214 may be disposed in an internal space of the housing 110, for example, an internal space corresponding to the main body 211. The internal space includes a first space S1 and a second space S2 located on both sides of the membrane 214, respectively.
[0453] In FIG. 18, the space farther from the shaft 220 with respect to the membrane 214 as the reference is shown as a first space S1, and the space adjacent to the shaft 220 with respect to the membrane 214 as the reference is shown as a second space S2.
[0454] The membrane 214 may have a porous structure that allows the movement of fluids and ions. The membrane 214 may be, for example, a frit membrane produced by thermally sintering spherical silica. For example, the spherical silica used to form the membrane may have a diameter of about 20 nm to about 500 nm, specifically, about 30 nm to about 300 nm, and more specifically, about 40 nm to about 200 nm.
[0455] When the diameter of the spherical silica falls within the above-mentioned range, a pressure caused by the first fluid passing through the membrane 214, that is, a pressure sufficient to move the shaft 220, can be generated.
[0456] In the above embodiment, the membrane 214 is described as including spherical silica, but the membrane 214 is not limited to this.
[0457] In another embodiment, the membrane 214 is made of any material that can induce electrokinetic phenomena due to a zeta potential, such as porous silica or porous alumina, without being limited to a particular type.
[0458] Membrane 214 can have a thickness of about 20 μm to about 10 mm, specifically, can have a thickness of about 300 μm to about 5 mm, and more specifically, can have a thickness of about 1,000 μm to about 4 mm.
[0459] A first electrode body 250 and a second electrode body 260 are disposed on either side of the membrane 214. The first electrode body 250 may include a first porous plate 251 and a first electrode strip 252 disposed on a first side of the membrane 214. The second electrode body 260 may include a second porous plate 261 and a second electrode strip 262 disposed on a second side of the membrane 214.
[0460] The first and second porous plates 251, 261 may be disposed to contact opposite main surfaces of the membrane 214, respectively. The first and second porous plates 251, 261 may effectively transfer fluids and ions through their porous structures.
[0461] The first and second porous plates 251 and 261 may have a structure in which an electrochemically reactive material is formed on a porous base layer. The electrochemically reactive material may be formed by electrolytic deposition or coating on the porous base layer by a method such as electroless plating, vacuum deposition, coating, or a sol-gel process.
[0462] The porous base layer may be an insulator, for example, the porous base layer may be selectively applied with one or more of the materials described in the embodiment of FIG.
[0463] When the pore size of the porous support satisfies the above-mentioned range, the fluid and ions can be effectively transferred, and the stability, life characteristics, and efficiency of the pump unit 229 can be improved.
[0464] The electrochemical reactant may include a material that can form a pair of reactions in which the oxidizing electrode and the reducing electrode exchange cations, e.g., hydrogen ions, during the electrode reaction of the first and second electrode bodies 250 and 260, and can simultaneously form a reversible electrochemical reaction.
[0465] The electrochemically reactive material can include, for example, one or more selected from the group consisting of silver / silver oxide, silver / silver chloride, MnO(OH), polyaniline, polypyrrole, polythiophene, polythionine, quinone-based polymer, and combinations thereof.
[0466] The first and second strips 252, 262 may be disposed on edges of the first and second porous plates 251, 261 and may be connected to first and second terminals 253, 263 on the outside of the housing 210. The first and second strips 252, 262 may include a conductive material such as silver, copper, or the like.
[0467] The fluid provided in the internal space of the housing 210 may include a first fluid and a second fluid having different phases from each other. The first fluid may include a liquid such as water, and the second fluid may include a gas such as air.
[0468] The first fluid present in the internal space does not entirely fill the internal space, i.e., the volume of the internal space is greater than the volume of the first fluid present in the internal space, and the second fluid is present in the portion of the internal space where no water is present.
[0469] A sealant 217 is disposed on both sides of the structure of the membrane 214, the first electrode body 250, and the second electrode body 260. The sealant 217 may be annular in shape having an area corresponding to the edges of the aforementioned structures.
[0470] The aforementioned fluid, for example, the first fluid, moves from the first space S1 to the second space S2 or vice versa along the thickness direction of the membrane 214 so as to pass through the membrane 214, and at this time, the sealing material 217 seals the gap between the inner surface of the housing 210 and the aforementioned structure, thereby preventing the liquid from moving through the gap.
[0471] The behavior of the fluid and the resulting movement of the shaft will now be explained.
[0472] The first electrode body 250 and the second electrode body 260 are electrically connected to a power supply via first and second terminals 253, 263, respectively, and the polarity of the voltage supplied by the power supply can be alternated to change the direction of movement of liquids such as water.
[0473] As an embodiment, in the case where silver / silver oxide is used as the electrochemical reactant and the first fluid is a solution containing water, when the first electrode body 250 is an oxidation electrode and the second electrode body 260 is a reduction electrode, cations (e.g., hydrogen ions) generated by an oxidation reaction in the first electrode body 250 move through the membrane 214 toward the second electrode body 260 due to the voltage difference, and at this time, water (H2O) moves together with the cations, and a certain pressure may be generated.
[0474] Through such control, the movement of the shaft 220 of the pump portion 229 can be controlled.
[0475] FIG. 19 is a perspective view showing one optional embodiment of a drive unit included in a drug solution control injection device according to yet another embodiment of the present invention, and FIG. 20 is a cross-sectional view taken along line XX-XX in FIG. 19.
[0476] For example, Figures 19 and 20 show a pump unit 320 that can be applied to either a first drive unit of a first liquid drug injection unit, a second drive unit of a second liquid drug injection unit, or a common drive unit that is commonly applied, all of which are included in a liquid drug control injection device.
[0477] The pump portion 320 of this embodiment may include a connector 321 and a check valve assembly 323 , and may further include a drive member 325 .
[0478] The check valve assembly 323 may be coupled to one side of the connector 321, and the driving member 325 may be coupled to the other side of the connector 321. The connector 321 may be provided with a partition 321a that separates the check valve assembly 323 and the driving member 325. The partition 321a may be provided with an inlet 321b and an outlet 321c.
[0479] The inlet 321b and the outlet 321c are disposed at a distance from each other and penetrate the partition wall 321a.
[0480] The check valve assembly 323 may include a valve housing 357 , an inlet check valve 359 , an outlet check valve 361 , a first fixture 363 , and a second fixture 365 .
[0481] An inlet extension pipe 357a and an outlet extension pipe 357b may be provided in the valve housing 357. The valve housing 357 may be coupled to one side of the connector 321. The inlet extension pipe 357a is connected to the inlet 321b, and the outlet extension pipe 357b is connected to the outlet 321c.
[0482] The inlet check valve 359 is disposed in the inlet extension pipe 357a and can control the direction of flow of the fluid, and the outlet check valve 361 is disposed in the outlet extension pipe 357b and can control the direction of flow of the fluid.
[0483] Duckbill valves, which are flexible and have low opening pressure, can be used as the inlet check valve 359 and the outlet check valve 361. Such inlet check valve 359 and outlet check valve 361 can increase the fluid transmission efficiency relative to power consumption, can operate for a long time, and can increase marketability.
[0484] The first fixture 363 may be fitted into the inlet extension pipe 357a to fix the inlet check valve 359. The second fixture 365 may be fitted into the outlet extension pipe 357b to fix the outlet check valve 361.
[0485] First fixture 363 and second fixture 365 preferably comprise conduits.
[0486] In the embodiment of the present invention, an example in which the inlet check valve 359 and the outlet check valve 361 are coupled to the valve housing 357 has been described, but the present invention is not limited thereto, and the inlet check valve 359 and the outlet check valve 361 may be coupled to the inlet 321b and the outlet 321c provided in the connector 321, respectively. This other example can be manufactured with a simpler structure by forming the valve housing 357 integrally with the connector 321. This other example of the embodiment of the present invention can reduce the number of parts, further reducing manufacturing costs and can be manufactured in a compact size.
[0487] The driving member 325 is coupled to one side of the connector 321. The driving member 325 is preferably disposed on the opposite side to which the check valve assembly 323 is coupled. The driving member 325 is preferably disposed isolated from the fluid passing through the check valve assembly 323. The driving member 325 can provide pressure to the fluid passing through the check valve assembly 323.
[0488] The drive member 325 may include a first diaphragm 367 , a first pump housing 329 , a first power supply line 371 , a first electrode 373 , a membrane 327 , a second electrode 377 , a second power supply line 379 , a second pump housing 381 , and a second diaphragm 383 .
[0489] The first diaphragm 367 is coupled to one side of the connector 321. A space may be provided between the first diaphragm 367 and the connector 321. That is, the first diaphragm 367 is coupled to the connector 321 while maintaining a certain space therebetween. Therefore, the fluid on the check valve assembly 323 side is kept isolated by the first diaphragm 367 without moving to the actuating member 325 side.
[0490] The surface of the first diaphragm 367 can repeatedly move a certain distance in the axial direction due to the pressure generated by the driving member 325. The first diaphragm 367 may have a wrinkled portion that allows the surface to move smoothly in the axial direction.
[0491] The above-mentioned first diaphragm 367 is coupled to one side of the first pump housing 329. A space 329a may be provided penetrating the first pump housing 329 along the axial direction. Therefore, the first pump housing 329 may close one side of the space 329a by the first diaphragm 367.
[0492] A first electrode 373 may be coupled to the other side of the first pump housing 329 to close a space 329a formed by the first pump housing 329. The first pump housing 329 may accommodate a working fluid such as water in the space 329a formed therein.
[0493] The first pump housing 329 may have a fluid injection hole 329b formed on the outer periphery. The hole 329b may be sealed after the working fluid is injected into the first pump housing 329. Therefore, the working fluid in the driving member 325 may be isolated from the chemical liquid on the check valve assembly 323 side.
[0494] The first power supply line 371 can supply power to the first electrode 373. The first power supply line 371 can be arranged along the frame of the first pump housing 329 and can be fixed in contact with the first electrode 373. The first power supply line 371 is preferably arranged between the first pump housing 329 and the first electrode 373. However, as another example of the embodiment of the present invention, the first power supply line 371 can also be arranged between the first electrode 373 and the membrane 327 as long as it can simply supply power to the first electrode 373.
[0495] The first electrode 373 has a plate shape and can close the space 329a of the first pump housing 329. That is, the first pump housing 329 can form the space 329a by the first diaphragm 367 and the first electrode 373. A working fluid such as water is stored in the space 329a of the first pump housing 329.
[0496] Membrane 327 may be made of a porous material through which the working fluid and ions can move. Membrane 327 is preferably made of a non-conductor such as ceramic. When membrane 327 is made of a non-conductor, even if the electrochemically reactive material used in first electrode 373 and second electrode 377 is consumed or detached and porous membrane 327 is exposed when the electroosmotic pump of the present invention is operated for a long period of time, no side reaction occurs. Therefore, unnecessary power consumption due to side reactions can be prevented. Therefore, the present invention has safe operating characteristics and can improve durability.
[0497] The membrane 327 can be made of a flexible material such as a non-conductive polymer resin, rubber, urethane, or plastic film processed into a thin film.
[0498] The second electrode 377 is disposed on the other side of the membrane 327. That is, the membrane 327 is preferably disposed between the first electrode 373 and the second electrode 377. The second power supply line 379 can supply external power to the second electrode 377. The second power supply line 379 can be coupled to the frame of the second pump housing 381. However, the second power supply line 379 can have any arrangement structure as long as it is simply a structure capable of supplying power to the second electrode 377.
[0499] The second pump housing 381 has the same or similar shape and pattern as the first pump housing 329. The second pump housing 381 may have another space 381a penetrating therein in the axial direction. The second pump housing 381 may have a hole 381b penetrating the internal space 381a, similar to the first pump housing 329. The hole 381b of the second pump housing 381 may be sealed with a sealant after injecting the working fluid, or may be embedded by fusion or the like.
[0500] The second diaphragm 383 is coupled to one side of the second pump housing 381 and can close a space 381 a provided in the second pump housing 381 .
[0501] That is, the second pump housing 381 can close the space 381 a by the plate-shaped second electrode 377 and the second diaphragm 383 .
[0502] The second diaphragm 383 may have a wrinkled portion 383a formed on its surface. The wrinkled portion 383a formed on the second diaphragm 383 may be formed as unevenness protruding in the axial direction when viewed based on a cross section. The wrinkled portion 383a of the second diaphragm 383 may play a role in sufficiently moving the surface of the second diaphragm 383 in the axial direction to increase pumping performance.
[0503] In the embodiment of the present invention, an example in which the wrinkles 383a are formed in the second diaphragm 383 has been illustrated and described, but in some cases, wrinkles may also be formed in the first diaphragm 367. The wrinkles that can be formed in the first diaphragm 367 or the second diaphragm 383 can maximize the deformation of the first diaphragm 367 and the second diaphragm 383 even with low energy, thereby reducing energy consumption. In other words, there is an advantage in that the driving member 325 can be driven for a long time even with a low external power supply.
[0504] The first pump housing 329, the first power supply line 371, the first electrode 373, the membrane 327, the second electrode 377, the second power supply line 379, and the second pump housing 381 can maintain airtightness from the outside by the sealant S. That is, the first power supply line 371, the first electrode 373, the membrane 327, the second electrode 377, and the second power supply line 379 can be configured and assembled to be smaller than the sizes of the first pump housing 329 and the second pump housing 381, and the sealant S can be disposed in a peripheral portion (a portion exposed to the outside, which forms a groove or space based on a cross section) between the first pump housing 329 and the second pump housing 381. Such a sealant S can form an airtight layer that maintains airtightness from the outside.
[0505] FIG. 21 is a perspective view of yet another alternative embodiment of a drug solution controlling infusion device according to yet another embodiment of the present invention.
[0506] With reference to FIG. 21, the medical fluid control infusion device 9000 can include a cover portion 9250 and a base plate 9260 .
[0507] At least one or a plurality of regions of the blood glucose measuring unit, the first liquid medicine injecting unit, and the second liquid medicine injecting unit in the above-described embodiments can be disposed on or supported by the base plate 9260, and can be covered by the cover unit 9250. This allows the liquid medicine control injection device 9200 to be used as an integrated module, improving user convenience. Of course, the first liquid medicine injecting unit and the second liquid medicine injecting unit can also be housed in separate housings.
[0508] Also, as an alternative embodiment, the medical fluid control infusion device 9000 may be connected to an external terminal MDV, and a user may receive information from the medical fluid control infusion device 9000 through the terminal MDV, and as another example, may start or stop the operation of the medical fluid control infusion device 9000 through the terminal MDV.
[0509] In addition, the operating state and performance status of the drug solution control injection device 9000 can be grasped periodically or in real time.
[0510] For this purpose, the terminal MDV can be connected to the drug solution control infusion device 9000 via a wired or wireless communication module, and the drug solution control infusion device 9000 can include such a communication module.
[0511] This improves the convenience of injecting medicinal liquid into the injection subject, and more specifically, makes it possible to easily realize precise control of the first and second medicinal liquids, which are different medicinal liquids when blood sugar decreases and increases.
[0512] In addition, users such as the subject of drug injection, the guardian of the subject of drug injection, and medical personnel can easily check information about the drug injection and blood sugar changes after the drug injection, thereby enabling precise control of the blood sugar management of the subject.
[0513] Thus, the present invention has been described with reference to the embodiments shown in the drawings, but these are merely illustrative, and those skilled in the art will appreciate that various modifications and equivalent embodiments are possible. Therefore, the true technical scope of the present invention should be determined by the technical ideas of the appended claims.
[0514] The use of the term "above" and similar indicators in the description of the embodiments (particularly in the claims) may correspond to both the singular and plural forms. In addition, when a range is described in the embodiments, it includes the invention to which each individual value belonging to the above range is applied (unless otherwise stated), and is the same as describing each individual value constituting the above range in the detailed description. Finally, unless otherwise stated, the steps constituting the method according to the embodiment are clearly described in order, the steps may be performed in an appropriate order. The embodiment is not necessarily limited by the order of the steps described above. The use of all examples or exemplary terms (for example, etc.) in the embodiments is merely for the purpose of describing the embodiments in detail, and the scope of the embodiments is not limited by the above examples or exemplary terms unless otherwise limited by the claims. Furthermore, a person of ordinary skill in the art will understand that various modifications, combinations and changes may be made according to design conditions and factors within the scope of the appended claims or their equivalents. [Industrial Applicability]
[0515] The specific implementation described in the embodiment is one embodiment and does not limit the scope of the embodiment in any way. For the sake of brevity of this specification, descriptions of conventional electronic configurations, control systems, software, and other functional aspects of the system may be omitted. Furthermore, the line connections or connecting members between components shown in the drawings are illustrative of functional connections and / or physical or circuit connections, and may be shown as various alternative or additional functional connections, physical connections, or circuit connections in an actual device. Furthermore, unless specifically mentioned as "essential", "important", etc., a component may not necessarily be required to apply the present invention.
Claims
[Claim 1] A blood glucose measuring unit configured to measure the blood glucose of the subject at least sequentially multiple times; A first medicinal liquid injecting section configured to inject a first medicinal liquid containing a component that controls a decrease in blood glucose of the injection target into the injection target; A drug solution control injection device comprising: a second drug solution injection section configured to inject a second drug solution containing a component that controls an increase in blood sugar of the injection subject and that contains a component different from the first drug solution into the injection subject.
Citation Information
Cited By
Image processing apparatus, image processing method, storage medium, and computer program product
CN121639761A
Image processing apparatus, image processing method, and storage medium
EP4708195A1
